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Adequate nutrition is essential for survival, growth and development. Newborns 
and infants are in a stage of rapid somatic and developmental growth. High 
metabolic demands, limited nutritional reserves, and physiological immaturity put 
them at risk for developing both short- and long term consequences of malnutri-
tion.1-5 Critical illness and major surgery elicit a stress response that augments 
the risk of malnutrition and the morbidity and mortality associated with malnutri-
tion. 
 
A mild catabolic reaction accompanies all infections, and many other diseases, 
even when subclinical.6 The neuroendocrine and humoral changes induced by 
critical illness and major surgery, however, result in hypermetabolism and ca-
tabolism, to the extent that outright protein-energy malnutrition may occur.7,8 
Both acute and chronic protein-energy malnutrition are frequently seen in pediat-
ric in-hospital patients and in pediatric intensive care patients.1,2,9-11 Patients un-
der two years of age and patients with a surgical condition are at highest risk of 
malnutrition.1,2 
 
Acute protein-energy malnutrition is associated with increased physiological in-
stability and quantity of care, and increased mortality.8,12 Malnutrition affects the 
immune response and renders the critically ill child more susceptible to infec-
tion.6,8,13 Malnutrition may also result in impaired wound healing and in clinically 
relevant dysfunction of the respiratory, cardiovascular and digestive system.8,14 
 
Hypermetabolism and catabolism are considered key features of the response to 
critical illness and major surgery, crucial to the development of critical illness-re-
lated protein-energy malnutrition. In children, like in adults, energy expenditure 
is proportionate to the severity of illness, surgery or trauma,15-20 though it does 
not increase to the same extent.17,19,21 Energy expenditure may even be lower 
than predicted,10,22-24 or than observed in normal children.18,20,25 Overfeeding the 
critically ill child therefore is very well possible.26 Like underfeeding, overfeeding 
can have detrimental effects: it may compromise immunity, increase energy ex-
penditure, compromise the respiratory system and lead to lipogenesis and hepatic 
steatosis.8,13,26-28 Moreover, overfeeding cannot reverse catabolism until the 
stress response has resolved.26 
The dynamics of the response to stress are age-related. In newborns and young 
infants, stress hormone levels, energy expenditure and nitrogen excretion may 
normalise within hours to days after major surgery.19,29-31 In view of the observa-
tion that infants and patients with a surgical condition are at high risk to develop 
malnutrition,1,2,32 it seems likely that this subpopulation of pediatric patients may 
benefit from early and aggressive nutritional support. 
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Nutritional support can be provided via the enteral route or via the parenteral 
route. Both routes have complications (Table 1.1).33,34 Use of the enteral route in 
adults has been associated with a lower incidence of infections, better outcome, 
and lower costs.35-38 Although the validity and implications of these findings are 
still being contested, the enteral route is now generally preferred for ICU pa-
tients.39-46 Findings in pediatric ICU populations mirror those in adults: enteral 
nutrition in critically ill children seems feasible and cost-effective,47-49 but may 
result in low caloric intake, gastric residuals, vomiting, pulmonary aspiration and 
diarrhea.48-52 In children, just as in adults, the enteral route is the preferred route 
for nutritional support.53 If the function of the gastrointestinal tract is impaired, 
Enteral nutrition Parenteral nutrition 
  
Mechanical Mechanical 
Improper feeding tube size or placement Improper catheter size or placement 
(pneumothorax, hematothorax) 
Feeding tube dislocation Catheter dislocation 
Feeding tube obstruction Catheter obstruction 
Intestinal perforation Perforation of large vein (hematothorax, 
pericardial tamponade) 
 Phlebitis 
 Thrombosis 
 Air embolus 
  
Gastrointestinal Gastrointestinal 
Gastric residuals, nausea, vomiting Intestinal atrophy 
Diarrhea Loss of gut barrier function 
Constipation, bloating Cholestasis, liver failure 
  
Infectious Infectious 
Aspiration pneumonia Sepsis; catheter-related infection 
  
Nutritional / metabolic Nutritional / metabolic 
Inadequate delivery of calories Overfeeding 
Hyperglycemia, hypoglycemia Hyperglycemia, hypoglycemia 
Electrolyte disorders Electrolyte disorders 
Phosphate disorders Phosphate disorders 
Azotemia Azotemia 
Hyperlipidemia Hypertriglyceridemia 
Liver function test abnormalities Liver function test abnormalities 
 Hyperammonemia 
 Deficiency of vitamins, trace elements, 
essential fatty acids 
  
Table 1.1 Complications of enteral and parenteral nutrition 
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however, parenteral nutrition may -and probably should- be used as an adjunct 
to enteral nutrition. The indication for total parenteral nutrition has been nar-
rowed down to a non-functioning gastrointestinal tract.53 Examples of impaired 
function or non-function of the gastrointestinal tract include intestinal obstruction, 
recent gastrointestinal surgery, necrotizing enterocolitis, and severe intestinal or 
global hypoxia-ischemia, such as may occur in midgut volvulus or critical illness.53 
 
Gastrointestinal function is a complex issue. Barrier function, gut-related immu-
nity, splanchnic blood flow and nutrient absorption are interrelated components of 
this function that may be impaired in the setting of critical illness and gastroin-
testinal surgery.54 An intact barrier function of the gut prevents or limits bacterial 
translocation, i.e. the absorption of microorganisms and toxins. Intestinal hyper-
permeability is seen in critical illness and after gastrointestinal surgery, and has 
been associated with increased morbidity and mortality.55-57 Apparent or true hy-
perpermeability may be caused by intestinal or global ischemia.58 The exact rela-
tion between intestinal hyperpermeability and increased bacterial translocation, 
however, and the clinical relevancy of bacterial translocation are still being unrav-
eled.55-57,59,60 Be that as it may, increased bacterial translocation should in all 
likelihood be considered a sign of an altered balance of nonimmunologic and im-
munologic host defenses on the one hand, and changing virulence of indigenous 
bacteria on the other hand.60 Moreover, gastrointestinal dysfunction in critical ill-
ness is considered an instrumental early event of a sequence that may result in 
septic inflammatory response syndrome and multiple organ failure. 
 
In the case of poor gastrointestinal function, the choice how to provide nutritional 
support is delicate. Enteral nutrition, if started in an early phase of critical illness, 
is believed to preserve or restore gut barrier function and to attenuate the 
hypermetabolic stress reponse.61 In surgical infants receiving total parenteral nu-
trition, even small quantities of enteral nutrition improve immune function.62 In 
premature newborns, progression from minimal enteral nutrition to full enteral 
nutrition in the first days of life appears to increase the incidence of necrotizing 
enterocolitis,63 whereas early reintroduction of enteral nutrition after necrotizing 
enterocolitis may reduce length of hospital stay.64 Parenteral nutrition is more 
likely to provide the target intake and thus to attenuate or reverse the progres-
sion of malnutrition,51,52 but may impair immunity65,66 and cause or aggravate 
intestinal hyperpermeability67-69 and cholestasis.70 
AIM OF THIS THESIS 
This thesis describes studies on the interaction of nutrition and gastrointestinal 
function in newborns and infants who require surgical treatment for diseases en-
tailing poor gastrointestinal function. 
 Chapter 1 12
The studies described in chapters 2 to 4 aim to delineate the indications for total 
parenteral versus enteral nutrition in the setting of critical illness: 
• In Chapter 2 we assess whether the sugar absorption test, a measure of in-
testinal permeability, may serve as a tool to time the (re-)introduction of en-
teral nutrition in patients suffering from necrotizing enterocolitis. 
• In Chapter 3 the same sugar absorption test is used to assess whether in-
testinal permeability and absorptive capacity are affected by the route of 
feeding in newborns treated with extracorporeal membrane oxygenation. 
• In Chapter 4 we assess whether the incidence of septic complications in 
newborns treated with extracorporeal membrane oxygenation is affected by 
the route of feeding. 
The studies described in chapters 5 and 6 aim to critically appraise widely held 
notions about parenteral nutrition: 
• In Chapter 5 we assess the relation between septic events and parenteral 
nutrition-associated cholestasis in surgical newborns with an intestinal anom-
aly. 
• In Chapter 6 we assess the clinical relevancy of nonurinary nitrogen excre-
tion compared with urinary nitrogen excretion, in newborns and infants re-
ceiving total parenteral nutrition after major digestive tract surgery. 
The study described in chapter 7 aims to attenuate the adverse effects of par-
enteral nutrition by improving the composition of the amino acid mixture: 
• In Chapter 7 we assess the effects of glutamine supplementation of par-
enteral nutrition in newborns and infants after major digestive tract surgery, 
with emphasis on intestinal permeability and nitrogen balance. 
 
In Chapter 8 we summarize our findings and discuss them in a broader context. 
Chapter 9 is a summary in Dutch. 
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ABSTRACT 
BACKGROUND: In necrotizing enterocolitis (NEC), (sub)mucosal edema, hemor-
rhage, ulceration and/or necrosis will disturb intestinal integrity, as reflected by 
an increased intestinal permeability. In many clinics, enteral substrate is there-
fore withheld for a variable period up to three weeks. We used the sugar absorp-
tion test to measure changes of intestinal permeability in surgically treated NEC 
patients and surgical controls, in order to evaluate the usefulness of this test in 
timing the (re-)introduction of enteral feeding in NEC patients as intestinal 
integrity recovers. 
METHODS: Changes in intestinal permeability to lactulose and rhamnose were pro-
spectively evaluated in thirteen children with necrotizing enterocolitis and ten op-
erated control patients. The patients were given 1 mL/kg body weight lactu-
lose/rhamnose solution at different time intervals after admission. The lactu-
lose/rhamnose ratio was determined by gaschromatography in 4-hour urine sam-
ples. 
RESULTS: The L/R ratios in NEC patients were increased for prolonged periods of 
time with a tendency to decrease in the third week after the start of NEC. How-
ever, in some cases, the increased L/R ratios even exceeded the 3-week period of 
starvation. High peaks in the L/R ratio were seen in patients suffering from bowel 
perforation or sepsis. Compared to NEC patients, L/R ratios of control patients 
were increased only in the first days after surgery and normalized more rapidly. 
The results of the L/R tests in this study corroborated the clinical condition of the 
patients. 
CONCLUSION: In a group of seriously ill newborns with advanced stages of NEC, the 
sugar absorption test shows individual variability in the recovery of intestinal 
permeability. An individual approach in restarting enteral nutrition seems to be 
justified; however, the optimal timepoint to restart enteral nutrition cannot be 
determined by the sugar absorption test alone. Combining parameters of intesti-
nal integrity and function could enable a more accurate determination of this op-
timal timepoint. 
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INTRODUCTION 
Necrotizing enterocolitis (NEC) is a life-threatening condition, in over 90% of 
cases affecting premature neonates. NEC is a worldwide problem with an inci-
dence of 1 to 3 cases in 1,000 live births.1 During the past two decades its inci-
dence has increased, largely because more infants of lower gestational age sur-
vive.2 In the United States, its mortality rate is 13.1 deaths in 100,000 live births, 
or 20% to 40% of all cases.3 NEC is a disease of the immature mucosal barrier. 
Three major factors are claimed to be involved in the pathogenesis: enteral nutri-
tion, intestinal ischemia, and colonization of the gut by pathogenic bacteria. Focal 
or diffuse mucosal ulceration, submucosal edema, hemorrhage, and necrosis in-
crease the intestinal permeability.4 Initial treatment usually consists of broad-
spectrum antibiotics and bowel starvation, supported by total parenteral nutrition 
for a period up to 3 weeks. Pneumoperitoneum and/or persistent acidosis with 
continuing deterioration of the clinical condition are indications for surgery.5 Ob-
jective criteria for the optimal timing of (re-)introduction of enteral nutrition in 
these patients are not available. Studies in critically ill adults document that im-
pairment of the mucosal barrier function, together with overgrowth of pathogenic 
bacteria within the gastrointestinal tract, enhances translocation of bacteria and 
endotoxins. Consequently, various inflammatory mediators are activated, result-
ing in systemic inflammatory response syndrome, sepsis, and multiple organ fail-
ure.6-9 Early (re-)introduction of enteral nutrition in the critically ill (“minimal en-
teral feeding”) helps to preserve an intact intestinal mucosal barrier function du-
ring critical illness.10,11 
The sugar absorption test (SAT) is a noninvasive and reliable test to evaluate ab-
normal intestinal permeability under different conditions such as coeliac disease, 
cystic fibrosis and Crohn’s disease. It enables the physician to monitor the condi-
tion of the diseased bowel, both in children and adults.12 The SAT measures uri-
nary excretion of orally administered inert markers with high renal clearance 
rates. In this study we measured changes in intestinal permeability to lactulose, 
rhamnose and xylose to evaluate the usefulness of this test in timing the (re-)in-
troduction of enteral feeding in NEC patients as intestinal integrity recovers. Most 
patients were operated in the acute phase of NEC. In order to evaluate the effect 
of abdominal surgery versus intestinal disease and surgery, patients undergoing 
surgery with bowel handling such as in case of diaphragmatic hernia, malrotation 
and esophageal atresia, served as controls. 
MATERIALS AND METHODS 
After institutional approval, thirteen NEC patients admitted to the department of 
Pediatric Surgery were subjected to the SAT. Patient characteristics are shown in 
Table 2.1. The mean gestational age was 34 weeks (range 28 to 40 weeks), and 
the mean birth weight 1,900 g (range 1,020-3,090 g). In all patients the diagno-
sis of NEC was asserted in accordance with stages 2 (two patients) and 3 (eleven
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patients) of Bell’s classification.13 In eleven patients surgery was performed be-
cause the bowel perforated in the course of NEC or because the patient’s condi-
tion deteriorated rapidly. Eight patients suffered from bowel perforation within 5 
days after the start of NEC. In one patient (No. 9) the bowel perforated on day 10 
after the start of NEC. After resection of the necrotic bowel part(s), an ileostomy 
was placed in eight patients and a colostomy in two patients. In one patient a 
laparotomy was performed without resecting bowel parts, and two patients were 
treated conservatively. In one patient (No. 8) multiple intestinal strictures were 
diagnosed and managed surgically 5 weeks after start of NEC. As part of the sup-
portive therapy following the diagnosis of NEC, all patients were starved. Accord-
ing to our protocol starvation lasted for 3 weeks and during this period all pa-
tients received total parenteral nutrition. Broad-spectrum antibiotics were admin-
istered to all patients. Ten patients were mechanically ventilated following admis-
sion. In three patients persistent hypotension necessitated treatment with 
inotropic medication. Patients 8 through 11 and 13 were starved a few days 
longer than the other NEC patients because their clinical condition was still com-
promised at the end of the third week (three patients were recovering from sepsis 
and two patients suffered from abdominal distension).  
In the same period gut permeability was measured in ten control patients who 
had undergone surgery including bowel handling. Patient characteristics of the 
control patients are shown in Table 2.2. The mean gestational age was 37 weeks 
(range 33-40 weeks), the mean birth weight 2,900 g (range 1,860-4,200 g). All 
patients were fed parenterally. Eight patients were mechanically ventilated. In 
one patient low systemic bloodpressure was treated with inotropic medication. In 
three patients, who suffered from a congenital diaphragmatic hernia, the dia-
phragm was closed. An ileostomy was placed in three other patients. In two pa-
tients an esophageal atresia with a tracheoesophageal fistula was corrected. In 
one patient a malrotation, resulting in intestinal obstruction, was diagnosed and 
managed surgically, and in one patient with gastroschisis the abdominal wall 
defect was closed. 
The sugar absorption test solution was prepared by the hospital pharmacy. One 
hundred fourty milligrams of glucose, 140 mg of rhamnose and 70 mg of xylose 
were dissolved in 50 mL demineralized water. A total of 8.6 g of lactulose was 
added, and demineralized water was added up to 100 mL. The osmolarity was 
measured in 15 samples and averaged 429 mosmol/L (range 410-452 mosmol/L). 
In each patient, 2 to 7 lactulose/rhamnose (L/R) tests were performed during the 
acute phase of NEC and after surgery. Testing at predetermined time points fol-
lowing the start of NEC (with 2- to3-day intervals) could not be realized in all 
cases because some patients were not admitted until surgery was indicated, and 
referred from the NICU of other hospitals. As a consequence they could not be 
measured at the start of NEC. Moreover, extremely ill patients were not tested 
because of hemodynamic or respiratory instability. As a result, fewer measure-
ments were performed in NEC patients in the first days after surgery. The accu-
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rate collection of a 4-hour urine sample was dif-
ficult, especially in female newborns, and the 
test had to be repeated in some cases. 
Patients were given 1 mL/kg body weight L/R 
solution via a nasogastric tube. All urine passed 
in the next 4 hours was collected.14 The urine 
volume was measured and 1 mL was frozen at –
80 oC. A volume corresponding with 0.66 µmol 
creatinine of the urine sample was dried in addi-
tion of 100 µL mannitol and silylated with 40 µL 
N,O- bis(trimethylsilyl)acetamide, 40 µL trimeth-
ylchloorsilane, and 80 µL pyridine (1 hour at 70 
oC). After prepurification, 1-2 µL was analyzed 
by capillary gas chromatography (CP-Sil-5 col-
umn, 25 m x 0.22 mm, oven program 100 to 
260 oC with 7 oC/min) and detected with a flame 
ionization detector.15 The concentrations of lac-
tulose, rhamnose and xylose were expressed in 
millimole per mole creatinine and as a percent-
age of the ingested dose. Intestinal permeability 
is increased if the L/R (lactulose-%/rhamnose-
%) ratio is above 0.05.14,16 
Comparisons were carried out using the Mann-
Whitney U test; significance was established at P 
<0.05. 
RESULTS 
During the acute phase of NEC, 2 patterns were 
found in thirteen patients. In seven NEC patients 
(Nos. 1-7) the L/R ratio was initially elevated 
and decreased to normal in the second or third 
week after the start of NEC (Table 2.3, Figure 
2.1). In the six other NEC patients (No. 8-13) 
the L/R ratio was still elevated at the end of the 
third week (Table 2.3, Figure 2.1). One patient 
(No. 8), first measured in the third week after 
the onset of NEC showed an increased ratio, 
which decreased within a week. In this patient 
the increased L/R ratio on day 19 correlated with 
bowel dilatation, clinical signs of sepsis, and 
positive blood cultures. In one other patient, 
(No. 9) the L/R ratio increased rapidly to 0.98 on 
No. NECday  L/R ratio 
   1 7 0.02 
 16 0.06 
 19 0.04 
2 4 0.06 
 8 0.10 
 11 0.04 
3 1 0.18 
 15 0.04 
 19 0.02 
4 4 0.06 
 6 0.08 
 11 0.08 
 18 0.02 
5 2 0.01 
 4 0.01 
 7 0.11 
 9 0.08 
 13 0.01 
6 5 0.07 
 12 0.09 
 19 0.03 
7 9 0.14 
 13 0.05 
 23 0.02 
8 19 0.34 
 25 0.10 
9 0 0.04 
 1 0.39 
 3 0.10 
 6 0.22 
 10 0.98 
 13 0.04 
 20 0.14 
10 11 0.08 
 15 0.04 
 18 0.02 
 21 0.14 
11 5 0.03 
 14 0.04 
 16 0.38 
 25 0.06 
12 6 0.17 
 13 0.10 
 20 0.06 
13 10 0.04 
 17 0.06 
 23 0.08 
   
Table 2.3 NEC patients 
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the tenth day after start of NEC, which coincided 
with a clinical deterioration of the patient’s con-
dition due to perforation of the bowel. One other 
patient (No. 11) had normal L/R ratios in the 
first 2 weeks after the start of NEC, but on day 
16 this ratio increased to 0.38. This patient also 
suffered from bowel dilatation and clinical signs 
of sepsis, although blood cultures remained 
negative. In two other patients (Nos. 10 and 13) 
the L/R ratios increased unexpected at the end 
of the third week. Both suffered from mild ab-
dominal distension, without any other signs of 
recurrent NEC or sepsis, which spontaneously 
disappeared within 2 days. In one patient (No. 
12) the increased L/R ratio of 0.17 on day 6 
slowly decreased to 0.06 on day 20. No signifi-
cant differences in gestational age, birth weight, 
NEC stage, days on the ventilator, and need of 
vasopressive medication were observed between 
the group with a normal and the group with an 
increased L/R ratio at the end of the third week 
(P >0.3). In all patients with a normal L/R ratio 
at the end of the third week, only the colon was 
involved as part of the disease process, whereas 
in five of six patients in the group with an in-
creased ratio at the end of the third week the 
small bowel was also involved. All patients tolerated the SAT well. 
All control patients but one (No. 3) showed increased ratios in the first days after 
surgery, which rapidly returned to or towards normal values within the first 10 
days (Table 2.4, Figure 2.2). In one control patient (No. 3), with a congenital dia-
phragmatic hernia, ratios were within the normal range at all time-points. The 
earlier results in control patients are further from the reference range than in 
those NEC patients. However, as stated earlier, fewer measurements were per-
formed in NEC patients in the first days after surgery, due to hemodynamic 
and/or respiratory instability. 
The mean L/R ratio of term-born patients in all groups was higher than the mean 
L/R ratio in prematures (0.083 vs. 0.058) but this difference was not statistically 
significant. D-xylose excretion percentages were measured as well in twelve NEC 
patients. They showed a wide variety of patterns and no specific relation with the 
patient’s clinical condition or the L/R ratios could be identified. 
No. Day after 
surgery 
L/R ratio 
 1 2 0.32 
 6 0.08 
2 0 0.06 
 1 0.04 
3 1 0.01 
 3 0.01 
 5 0.01 
4 3 0.21 
 5 0.05 
5 4 0.28 
 6 0.01 
 12 0.01 
6 5 0.06 
 9 0.07 
 11 0.06 
7 3 0.15 
 5 0.32 
 9 0.01 
8 4 0.20 
 11 <0.005 
9 0 0.09 
 2 0.02 
10 6 0.06 
 20 0.04 
Table 2.4 Control patients 
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DISCUSSION 
In this study, recovery of intestinal permeability in a group of seriously ill patients 
with advanced stages of NEC showed individual variability. Instead of the current 
practice to standardize starvation of these patients for 3 weeks, an individual ap-
proach in restarting enteral nutrition seems to be justified. The timing of 
(re-)introduction of enteral feeding is delicate, because 97% of cases of NEC oc-
cur in infants previously fed, and (early) enteral feeding in premature neonates is 
generally considered to be a risk factor for NEC.17 Techniques to determine gut 
permeability might be helpful for optimal timing of the reintroduction of enteral 
substrate. 
In the past, probe molecules as [51Cr] EDTA, D-xylose and mannitol have been 
studied. Radioactively labeled [51Cr] EDTA is less suitable for repeated measure-
ments, and the required 24-hour urine collection is a problem in small, critically ill 
newborns. The D-xylose test proved to be less reliable because of its frequent 
false-negative and false-positive results.18,19 Single marker excretion percentages 
are known to be influenced by numerous factors and because we found a wide 
variety of D-xylose excretion patterns in our study not concordant with the pa-
tient’s clinical condition or the L/R ratio, these data were left out of consideration. 
The variable natural excretion of mannitol in urine complicates the interpretation 
of the commonly used clinical tests using this marker.20 
We used lactulose and rhamnose as probe molecules in our study. When lactulose 
and rhamnose are combined in the test solution at a fixed concentration ratio, the 
effects of variables, such as gastric emptying, intestinal transit time, and renal 
clearance will apply equally to both. Thus the urine L/R ratio is only influenced by 
the difference in gut permeability for each molecule.12,18 Disaccharides such as 
lactulose are thought to traverse the mucosa by paracellular pathways via tight 
junctions between the enterocytes. Permeability of the tight junctions presumably 
increases in diseased or damaged mucosa, resulting in increased absorption of 
disaccharides. Monosaccharides such as rhamnose, on the other hand, predomi-
Figure 2.1 L/R ratios of NEC patients 
0,0
0,1
0,2
0,3
0,4
0,5
0 5 10 15 20 25
Day after surgery
L
/
R
 r
a
ti
o
Figure 2.2 L/R ratios of control patients 
0,0
0,1
0,2
0,3
0,4
0,5
0 5 10 15 20 25
NEC day
L
/
R
 r
a
ti
o
0.98 
 Chapter 2 26
nantly pass by transcellular pathways through aqueous pores into the enterocyte 
membrane that are too small to permit the passage of lactulose. In villous atro-
phy the intestinal surface area decreases, resulting in decreased absorption of 
monosaccharides.20 
In 1995, Bijlsma et al proposed an alternative model to explain clinically obtained 
dual-sugar absorption data.21 They hypothesized that the hyperosmolarity of vil-
lus tips is the result of the countercurrent exchanger features of the villus mi-
crovasculature in humans. The high urine recovery of monosaccharides is caused 
by solvent drag through pores that allow the passage of monosaccharides but not 
of disaccharides. Lactulose recovery may represent paracellular passive diffusion 
over the mucosal barrier as a whole, whereas monosaccharide recovery mainly 
depends on water absorption in the upper part of the villus. Because intestinal 
ischemia and necrosis are instrumental in the pathogenesis of NEC, the tissue 
osmolarity of the villus tips will be affected resulting in a decreased solvent drag 
and, thus, monosaccharide absorption. According to this hypothesis, the disac-
charide to monosaccharide ratio is primarily a standard for the normal metabolite 
absorption of villus epithelial cells and for normal villus flow rather than a pa-
rameter for gut permeability.21,22 Although improvement of the ratios is explained 
differently in the above-mentioned theory, the SAT may also serve as a parame-
ter for monitoring the condition of the diseased bowel. 
Beach et al showed increased permeability during the first week of life in neo-
nates of gestational age 31 to 36 weeks.14 Prematures of 26 to 29 weeks of ges-
tation showed a “mature” pattern of permeability at birth followed by a period of 
enhanced permeability after 3 to 4 weeks of life. Weaver et al showed that new-
borns born before 34 weeks’ gestation exhibited a higher intestinal permeability 
than more mature newborns and that all preterm babies showed an appreciable 
decline in lactulose absorption during the first week of oral feeding.23 Babies of 34 
to 37 weeks’ gestation achieved a mature intestinal permeability within 4 days 
after starting oral feedings. More recently, Shulman et al found increasing intesti-
nal permeability in preterm infants of 26 to 30 weeks of gestational age in the 
first 28 days of life, which declined afterward.24 In contrast to our data, all above-
mentioned studies were performed in enterally fed patients. Although the mean 
gestational ages of NEC and control patients differed by 3 weeks in our study (34 
vs. 37 weeks gestational age), there was no obvious relation between gestational 
age and increased permeability. Differences in L/R ratios between term and pre-
term born babies were not statistically significant and were primarily related to 
the degree of illness. We concluded that increased intestinal permeability for pro-
longed periods of time, as found in patients 8 through 13, is more likely to be 
caused by the primary disease process than by the surgical intervention. 
The results of the L/R tests in this study corroborated the clinical condition of the 
patients; increased L/R ratios in the second or third week after start of NEC were 
found only in those patients suffering from sepsis, bowel perforation, or bowel 
dilatation. 
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We do realize that the SAT is a small-bowel permeability test, especially suitable 
for patients with advanced stages of NEC. In these severely ill patients, surgery is 
often inevitable, and only then the affected bowel parts can be identified accu-
rately. 
Further work is necessary to compare the results of the SAT with other parame-
ters of bowel function and integrity, eventually leading to more individualized 
management of NEC patients. In some NEC patients enteral nutrition might be 
introduced earlier, which can favor the gastrointestinal immunological function 
and reduce total parenteral nutrition-related morbidity. 
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ABSTRACT 
BACKGROUND/PURPOSE: Neonates meeting criteria for extracorporeal membrane 
oxygenation (ECMO) often suffer from variable periods of hypoxia. During ECMO, 
starvation of the gut is common practice in many centers as splanchnic ischemia 
results in loss of intestinal integrity, which in turn predisposes for bacterial trans-
location and sepsis and eventually necrotizing enterocolitis (NEC) and multiorgan 
failure. However, minimal enteral feeding is thought to be of benefit in the criti-
cally ill. Data on intestinal integrity in newborns on ECMO and the effects of en-
teral nutrition are not available. This study prospectively evaluates the changes in 
small intestinal integrity in 16 neonatal ECMO patients. 
METHODS: With 2-day intervals, excretion percentages of lactulose/L-rhamnose 
(nonmediated diffusion), D-xylose (passive), and 3-O-methyl-D-glucose (active 
carrier-mediated transport) were measured by gas-liquid chromotography in a 4-
hour urine sample. After obtaining baseline data in nine patients, enteral feeding 
was started in the next seven patients between the third and the ninth day of 
ECMO.  
RESULTS: Thirteen patients had increased lactulose/L-rhamnose ratios (>0.05) 
consistent with increased intestinal permeablity. In three patients the lactulose/L-
rhamnose ratios were within the normal range. D-xylose excretion percentages 
were normal (or slightly increased) in 11 patients consistent with normal (or in-
creased) passive carrier-mediated transport. 3-O-methyl-D-glucose excretion 
percentages were decreased (<10%) in all but one patient, consistent with de-
creased active carrier-mediated transport. After introduction of enteral nutrition 
no significant changes of these parameters were seen. 
CONCLUSIONS: The authors conclude that intestinal integrity is compromised in 
neonates on ECMO and that introduction of enteral nutrition does not result in 
further deterioration. This conclusion does not support the practice of withholding 
enteral nutrition in critically ill newborns supported by ECMO. 
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INTRODUCTION 
Venoarterial extracorporeal membrane oxygenation (ECMO) is used to provide 
partial heart-lung bypass for neonates with life-threatening, reversible cardiopul-
monary failure unresponsive to more conventional therapies. Conditions most 
commonly treated with ECMO are meconium aspiration syndrome, persistent 
pulmonary hypertension, sepsis, pneumonia, severe asphyxia, or congenital dia-
phragmatic hernia. In most centers, patients meet ECMO criteria when they reach 
the 80th percentile for expected mortality.1-3 
Starvation of the gut supported by total parenteral nutrition is common practice 
in ECMO patients in many centers for different reasons. First, severe respiratory 
insufficiency, asphyxia, and/or prolonged periods of hypoxia with the need for 
vasopressive therapy are often present in neonates meeting ECMO criteria. These 
may result in splanchnic ischemia with progressive functional and histological 
changes associated with loss of mucosal barrier function.4 In newborns, intestinal 
ischemia predisposes for bacterial translocation and sepsis and eventually for the 
development of necrotizing enterocolitis.5,6 Second, during venoarterial ECMO, 
blood is being drained by gravity from the right atrium to a roller pump, wich 
propels it through the membrane oxygenator and a heat exchanger before it is 
returned to the body. The hemodynamic alterations in patients on ECMO may ad-
versely affect splanchnic circulation.7 Valid data about intestinal permeability and 
absorptive capacity changes in ECMO patients are not available. 
Recently, simple tests have been proposed for the evaluation of gut permeability, 
both in adults and children, including newborns.8,9 The sugar absorption test 
(SAT) measures urinary excretion of inert markers with high renal clearance rates 
after oral administration. The SAT is a practical and noninvasive method for as-
sessing intestinal permeability and absorption of neutral molecules. 
The aim of this study is to evaluate the changes in intestinal integriy during ECMO 
and before and after the start of (minimal) enteral nutrition using the SAT. The 
lactulose/L-rhamnose (L/R) ratio (nonmediated transport) was used as a pa-
rameter for intestinal permeability in combination with D-xylose (passive) and 3-
O-methyl-D-glucose (active carrier mediated transport) excretion percentages as 
parameters for intestinal absorption capacity for saccharides. 
MATERIALS AND METHODS 
Patients 
From January 1996 through February 1997, sixteen neonates were admitted to 
the department of Pediatric Surgery of the Sophia Children’s Hospital in Rotter-
dam for ECMO. Patient characteristics are shown in Tables 3.1 and 3.2. The mean 
gestational age was 40 weeks (range, 36 to 43 weeks), and the mean birth 
weight was 3,300 g (range, 2,160 to 4,500 g). In all patients ECMO treatment 
was started within the first week after birth (median, 1 day after birth: range, 12 
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hours to 7 days). Patients were on venoarterial ECMO with a median of 5 days 
(range, 3 to 21 days). Eleven patients suffered from meconium aspiration syn-
drome, two patients had a congenital diaphragmatic hernia, two patients suffered 
form idiopathic persistent pulmonary hypertension, and one patient showed clini-
cal signs of sepsis, although blood culture findings remained negative. In seven 
patients, enteral feeding was started between the third and ninth day of ECMO 
treatment (patients 10-16). One of these patients was fed with breast milk (pa-
tient 14), and four patients were fed standard formula. During ECMO four patients 
sufferd form blood culture-proven sepsis in the first 5 days after the start of 
ECMO (patient 3 with Escherichia coli, patients 5 and 7 with Staphylococcus epi-
dermidis, patient 9 with Staphylococcus warneri). None of the patients in this 
study showed any signs of necrotizing enterocolities (NEC). 
The sugar absorption test 
The test solution was prepared by the hospital pharmacy. One hundred forty mil-
ligrams of 3-O-methyl-D-glucose, 140 mg of L-rhamnose, and 70 mg of D-xylose 
were dissolved in 50 mL demineralized water. Lactulose, 50% 17.2 g was added, 
and demineralized water was added up to 100 mL. The osmolarity of the solution 
was measured in 15 samples and found to be 429 mOsm/L (range, 410 to 452 
mOsm/L). The first test during ECMO treatment was applied as soon as the pa-
tient started to produce urine (mostly within the first 2 days on  ECMO). There-
after, the test was repeated every other day. After 4 hours fasting (in case of the 
enterally fed patients), the patients were given 1mL/kg body weight test solution 
via a nasogastric tube. All urine passed in the next 4 hours was collected from the 
routinely placed urine catheter. The urine volume was measured, and 3 mL urine 
was frozen at –80 ˚C. An aliquot from the urine sample corresponding to 0.66 
µmol creatinine was blow dried under nitrogen after addition of 100 µL mannitol. 
Patient Gestational 
age (wk) 
Birth 
weight (g) 
Days on ECMO Diagnosis Outcome 
      
1 39 4300 6 sepsis survived 
2 41 3210 5 MAS survived 
3 43 3200 6 MAS survived 
4 41 4000 4 MAS survived 
5 40 4000 14 CDH died 
6 40 3500 3 MAS survived 
7 38 2160 4 CDH survived 
8 36 2735 4 PPHN survived 
9 39 3310 4 MAS survived 
      
Table 3.1 Characteristics of nine ECMO patients receiving total parenteral nutrition. 
CDH: congenital diaphragmatic hernia. MAS: meconium aspiration syndrome. PPHN: 
persistent pulmonary hypertension of the neonate. 
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The residue was persilylated in 40 µL N,O-bis(trimethyl)acetamide, 40 µL 
trimethylchloorsilane, and 80 µL pyridine during 1 hour at 70 ˚C.10 After cooling 
to room temperature, 1 to 2 µL of the solution was analysed by capillary gas-liq-
uid chromatography (CP-Sil-5-CB column, 25 m x 0.22 mm, 0.12 µm film thick-
ness, oven programme 100 to 245 ˚C, rate, 3 ˚C/min) and detection with a flame 
ionization detector. The concentrations of lactulose, L-rhamnose, D-xylose, and 3-
O-methyl-D-glucose were expressed in mg/L and as a percentage of the ingested 
dose. Intestinal permeability is considered to be normal if the L/R ratio (lactu-
lose%/rhamnose%) is below 0.05.11,12 Intestinal absorptive capacity for saccha-
rides is considered to be normal when excretion percentages of D-xylose (passive 
carrier-mediated transport) and 3-O-methyl-D-glucose (active carrier-mediated 
transport) are in the 10% to 30% range.7,13 
In four patients, the first SAT was performed when they were still oliguric (urine 
production <0.5 mL/kg/h), and the urine sample was too small to determine the 
D-xylose (in two cases) and/or the 3-O-methyl-D-glucose (in all four cases) ex-
cretion percentages. 
RESULTS 
L/R ratio 
The L/R ratio was increased (>0.05) in 28 of 48 measurements. In 5 of 28 in-
creased ratios the lactulose excretion percentage was increased (>1%). In 26 of 
28 increased ratios the L-rhamnose excretion percentage was decreased (<10%). 
In thirteen patients, the L/R ratios were increased during ECMO treatment. In 
three patients, (patients 1, 6, 11) all L/R ratios were within the normal range. In 
four other patients (patients 3, 5, 7, 9) L/R ratio peaked on day 3, 7, and 1, re-
spectively, coinciding with sepsis. In patient 7, who suffered from sepsis during 
the whole ECMO period, the second L/R ratio peak on day 8 coincided with a de-
Patient Gestational 
age (wk) 
Birth 
weight 
(g) 
Days on 
ECMO 
Diagnosis Outcome Start of 
enteral 
feeding  
       
1 40 3500 21 PPHN, tricuspid 
insufficiency 
survived day 9 
2 42 2340 13 MAS survived day 8 
3 40 3290 5 MAS survived day 4 
4 37 3000 4 MAS survived day 3 
5 39 4500 4 MAS survived day 3 
6 42 3500 6 MAS survived day 4 
7 39 2300 7 MAS survived day 3 
       
Table 3.2 Characteristics of seven ECMO patients receiving enteral nutrition. MAS: 
meconium aspiration syndrome. PPHN: persistent pulmonary hypertension of the neonate. 
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Figure 3.1 Lactulose-rhamnose ratios. Left panel: nine patients given total parenteral 
nutrition during the whole ECMO period. Right panel: seven patients in whom enteral nutri-
tion was started during ECMO. Open squares indicate start of enteral nutrition. Dotted line 
indicates upper limit of normal lactulose-rhamnose ratio. 
Figure 3.2 D-xylose excretion percentages. Left panel: nine patients given total paren-
teral nutrition during the whole ECMO period. Right panel: seven patients in whom enteral 
nutrition was started during ECMO. Dotted lines indicate lower and upper limit of normal D-
xylose excretion percentage. 
Figure 3.3 3-O-methyl-D-glucose excretion percentages. Left panel: nine patients 
given total parenteral nutrition during the whole ECMO period. Right panel: seven patients 
in whom enteral nutrition was started during ECMO. Dotted lines indicate lower and upper 
limit of normal 3-O-methyl-D-glucose excretion percentage. 
0.7 
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terioration of the patient’s clinical condition. In patient 10 the L/R ratio peak on 
day 14 coincided with cardiac cathetherization. In seven patients enteral nutrition 
was started; the ratio decreased in two patients, remained unchanged in one pa-
tient, initially increased and returned to normal within 1 week in one patient, and 
increased in three patients (in two of these patients, the SAT could be performed 
only once after the start of enteral nutrition, as they were weaned off ECMO 
within the next 48 hours; Fig.3.1). 
D-xylose excretion  
D-xylose excretion percentages were normal in 32 of 46 measurements, de-
creased in 7 of 46 measurements, and increased in 7 of 46 measurments. In five 
patients, D-xylose excretion percentages were decreased. In eleven patients, all 
D-xylose excretion percentages were within the normal range. After the start of 
enteral nutrition, the excretion percentages increased in three patients (mean, 
11%) and decreased in four patients (mean, 12.6%; Fig 3.2). 
3-0-methyl-D-glucose excretion 
3-O-methyl-D-glucose excretion percentages were normal in 13 of 44 measure-
ments and decreased in 31 of 44 measurements. Excretion percentages were de-
creased in fifteen patients. In one patient, who was on ECMO for 4 days, only 1 
measurement was performed, and this 3-O-methyl-D-glucose excretion percent-
age was within the normal range. After the start of enteral feeding, the excretion 
percentage increased in three patients (mean, 1.7%) and decreased in four pa-
tients (mean, 4%; Fig 3.3). All patients tolerated enteral feeding well; no adverse 
effects were observed. 
DISCUSSION 
After recurrent periods of hypoxia pre-ECMO and the use of vasopressive drugs, 
intestinal ischemia is likely to occur in ECMO patients. Intestinal ischemia causes 
time-dependent, progressive histological changes ranging from patchy, subepi-
thelial blebs on villus tips to frank detachment of enterocytes, loss of villi and 
crypt cells, and necrosis of the submucosa and the deeper layers of the intestinal 
wall.14-16 This impairs the mucosal barrier function and enhances bacterial trans-
location, which can result in sepsis, systemic inflammatory response syndrome, 
and multiple organ failure.17,18 Early introduction of enteral nutrition in critically ill 
patients maintains an intact intestinal mucosa and supports the intestinal barrier 
function during critical illness.19,20 No data are available about the intestinal func-
tion in neonates during ECMO treatment and it remains debatable whether enteral 
substrate should be withheld. 
Measuring intestinal permeability for sugars is a reliable test for functional integ-
rity of the mucosa and to demonstrate mucosal damage.8 Disaccharides like lac-
tulose are thought to permeate the intestinal mucosa through large pores of low 
incidence problably associated with the paracellular tight junction complexes of 
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the epithelial crypt cells. Monosaccharides like L-rhamnose pass the intestinal 
mucosa mainly by the transcellular route, through small water-filled pores in the 
villus enterocyte walls that are impermeable for larger molecules such as lactu-
lose.21 Impaired L-rhamnose absorption represents reduced absorptive area, and 
enhanced lactulose permeation represents increased permeability of large pores 
caused by mucosal damage. When lactulose and rhamnose are combined in a test 
solution at a fixed concentration ratio, the effects of variables, such as gastric 
emptying, intestinal transit time, and renal clearance apply equally to both com-
pounds.22 Lactulose and L-rhamnose pass the bowel wall by nonmediated diffu-
sion. D-xylose an 3-O-methyl-D-glucose are monosaccharides that pass the bowel 
by passive and active carrier-mediated transport, respectively. They are consid-
ered to be representative compounds for measuring the absorption of saccha-
rides.9 
This study shows that in thirteen ECMO patients the L/R ratios were increased. 
The increased lactulose and reduced L-rhamnose permeation across the intestinal 
wall presumably results from intestinal ischemia. During periods of hypoxia or 
hypoperfusion, the integrity of the tight junctions, and therefore of the mucosal 
barrier, may become impaired and result in an increased lactulose excretion per-
centage. At the same time, degradation of enterocytes at the villus tips, which 
are most prone to ischemic damage, can reduce the L-rhamnose permeation. 
In four patients, L/R ratio peaks coincided with sepsis. In sepsis the production of 
cytokines decreases the tight junctions’ resistances, thus enhancing permeation 
of lactulose and increasing intestinal permeablility.9 Passive carrier-mediated 
transport (D-xylose) was normal in most ECMO patients, whereas active carrier-
mediated transport (3-O-methyl-D-glucose) was reduced in most patients. A dif-
ference in the behaviour of each marker can be explained only at a mucosal level, 
as changes in variables like gastric emptying, intestinal transit time, and persis-
tently reduced splanchnic blood flow would be expected to affect all markers to a 
similar extent. Our findings suggest that intestinal ischemia affects the turn-over 
of saccharide carriers to a different extent. Ohri et al found dramatic reductions in 
both active and passive carrier-mediated transport and increased gut permeability 
in fourty-one and twenty-six adult cardiopulmonary bypass (CPB) patients 
respectively, coinciding with reduced mucosal blood flow.7,23 However, these adult 
patients were only on CPB for a few hours and didn’t suffer from asphyxia and/or 
hypoxia. Therefore, they cannot be compared with the patients in our study 
population. 
Recently, an alternative model has been proposed to explain clinically obtained 
dual-sugar absorption data.24,25 The human microvasculature of villi has the char-
acteristic features of a countercurrent exchanger, and consequently a high tissue 
osmolality is maintained at the tips of the villi. It is hypothesized that the high 
urine recovery of the monosaccharide is caused by solvent drag through pores 
that allow the passage of monosaccharides but not disaccharides. Whereas lactu-
lose recovery may represent paracellular passive diffusion over the mucosal bar-
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rier as a whole, monosaccharide recovery depends mainly on water absorption in 
the upper part of the villus. Changes in intestinal perfusion can cause changes in 
tissue osmolality at the tips of the villi, and the efficiency of this mechanism will 
be reduce in states of intestinal ischemia. According to this hypothesis, the L/R 
ratio is primarily a standard for the normal villus blood flow and for the normal 
functioning of epithelial villus cells rather than a parameter for gut permeability. 
Most increased L/R ratios in this study were caused by a decreased L-rhamnose 
excretion, and according to this theory, the intestinal ischemia in ECMO patients 
may have caused changes in the tissue osmolality of villus tips, which in turn may 
have affected solvent drag and carrier-mediated absorption of monosaccharides 
(to a different extent). 
In this study the introduction of enteral feeding in ECMO patients after determina-
tion of the L/R ratio and D-xylose and 3-O-methyl-D-glucose excretion percent-
ages did not cause a significant deterioration of these parameters. These findings 
do not support the practice of withholding enteral nutrition in critically ill new-
borns supported by ECMO. 
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ABSTRACT 
PURPOSE: The aim of this study was to compare the effects of enteral and total 
parenteral feeding on septic complications in neonates on extracorporeal mem-
brane oxygenation (ECMO). 
METHODS: Ninety-six neonates were on ECMO between January 1992 and February 
1998. Matching for diagnosis and exclusion of neonates with sepsis prior to ECMO 
or undergoing surgery on ECMO left sixteen enterally fed neonates (cases) and 
thirty-five parenterally fed neonates (controls) for analysis. Septic complications 
were scored using the criteria of the Society of Critical Care Medicine and the 
American College of Chest Physicians adapted to children. 
RESULTS: Both groups were comparable with respect to gestational age, sex and 
age at initiation of ECMO. The frequency of septic complications did not differ 
between cases and controls: no complications 75% vs. 69%, systemic inflamma-
tory response syndrome 13 vs. 6%, bacteraemia 6 vs. 14%, sepsis 6 vs. 11%. 
There were no complications associated with enteral feeding. The ECMO-run was 
significantly longer in the case group (median 161 vs. 111 hours, P = 0.01) and 
mortality was lower in the case group (0 versus 14%, P = 0.17). 
CONCLUSIONS: Enteral nutrition does not affect the risk of sepsis in neonates on 
ECMO when compared to total parenteral nutrition. Enteral nutrition is well toler-
ated and not associated with adverse effects. 
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INTRODUCTION 
Neonates suffering from severe cardiopulmonary failure unresponsive to maximal 
conventional treatment can be successfully treated with extracorporeal mem-
brane oxygenation (ECMO). Around 80% of infants predicted to have 80% mor-
tality with conventional treatment, survive after ECMO.1,2 Common indications for 
neonatal ECMO are meconium aspiration syndrome (MAS), congenital diaphrag-
matic hernia (CDH), persistent pulmonary hypertension of the newborn (PPHN), 
and sepsis.1-3 
Most centres feed ECMO-patients by total parenteral nutrition (TPN). It is argued 
that hypoxic episodes prior to ECMO and the use of vasoactive drugs during 
ECMO may compromise splanchnic blood flow and result in gut ischemia. As a 
consequence bacterial translocation and/or sepsis may develop, and possibly ne-
crotizing enterocolitis. Asphyxia, low splanchnic blood flow and enteral feeding 
are considered risk factors for the development of necrotizing enterocolitis in 
premature infants.4,5 On the other hand, several studies have shown that with-
holding enteral feeding leads to villous atrophy, decreased immunological function 
of the gut, increased gut mucosal permeability, and bacterial translocation, favor-
ing sepsis. In the critically ill, early initiation of enteral nutrition restores intestinal 
mucosal integrity, even when only minimal quantities are provided enterally, 
whereas TPN is associated with a persistent increase in gastro-intestinal mucosal 
permeability.6-8 In critically ill patients, enteral nutrition has also been associated 
with improved gastrointestinal immunological function, reduced septic morbidity 
and decreased cost.7,9 
By measuring the urinary excretion of the sugars lactulose and rhamnose, we 
showed that intestinal integrity is compromised in neonates on ECMO.10 The cur-
rent study was designed to compare septic complications in enterally fed and par-
enterally fed neonatal ECMO-patients. 
METHODS 
The Sophia Children’s Hospital is one of two level III hospitals appointed by the 
Dutch Health Council, to offer veno-arterial ECMO to neonates with a reversible 
respiratory disorder unresponsive to maximal conventional treatment. These two 
ECMO centres cover the whole of the Netherlands, approximately 15 million in-
habitants. Principal entry criteria are an alveolar-arterial oxygen gradient ex-
ceeding 600 or an oxygenation index greater than or equal to 40 for at least 6 to 
8 hours. Contraindications are gestational age under 35 weeks, weight under 
2000 grams, intracranial haemorrhage grade II or more, and severe cardiac or 
chromosomal anomalies. 
In January 1996 enteral feeding in neonatal ECMO-patients was introduced into 
everyday clinical practice. Since then all patients, except patients with a con-
genital diaphragmatic hernia undergoing continuous suctioning of the nasogastric 
tube combined with post-ECMO repair of the diaphragmatic defect, have been fed 
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breast milk or standard formula (Nutrilon Premium, Nutricia, The Netherlands) 
through a nasogastric tube. Feedings are initiated at a rate of 0.5-1 mL/kg/h and 
increased each day by 0.5-1 mL/kg/h as tolerated. Complementary parenteral 
nutrition is given so as to maintain constant caloric and fluid intake. Care is taken 
to avoid excessive caloric intake.11 The charts of neonates on ECMO between 
January 1992 and February 1998 were reviewed. Patients were split into an 
enterally fed group (cases) and a parenterally fed group (controls). Patients were 
matched for diagnosis by excluding patients from the parenterally fed group with 
a primary or secondary diagnosis not present in the enterally fed group. Patients 
with clinically suspected sepsis prior to ECMO and patients undergoing surgery 
while on ECMO were excluded as well. 
The following data were collected: sex, birth-weight, gestational age, diagnosis, 
age and weight at initiation of ECMO, weight immediately after ECMO, time on 
ECMO, type and absolute and relative volumes of enteral and parenteral nutrition, 
vasopressive and antibiotic medication, results of blood cultures, clinical course 
and outcome. Infectious complications were scored using the classification pro-
posed by the Society of Critical Care Medicine (SCCM) and the American College 
of Chest Physicians (ACCP), adapted to children.12,13 On the basis of this classifi-
cation four categories were distinguished: (1) negative, i.e. no septic complica-
tions, (2) systemic inflammatory response syndrome (SIRS), (3) bacteraemia, 
and (4) sepsis. Patients with SIRS and at least one positive blood-culture were 
considered to have sepsis. Respiratory rate was not considered relevant for scor-
ing, since ECMO-pa-
tients are ventilated 
with standardised 
minimal respiratory 
settings. Specimens 
for blood culture 
were obtained daily 
during the ECMO-
run, and when sep-
sis was suspected. 
Cultures were proc-
essed in a conven-
tional two bottle 
(aerobic and an-
aerobic) broth blood 
culture system. All 
patients received 
intravenous broad 
spectrum antibiotics 
according to proto-
col before ECMO 
 Cases (n=16) Controls (n=35)
      
Gestational age (wk)* 40 (37-42) 40 (36-43) 
Birth-weight (kg)* 3.6 (2.2-4.5) 3.5 (2.4-4.9) 
Age at start ECMO (h)* 20 (10-84) 25 (8-133) 
Time on ECMO† (h)* 161 (87-356) 111 (64-279) 
Weight after ECMO (kg) 3.7 (2.3-5.6) 3.9 (3.2-5.2) 
Sex (%)     
Male 7 (44) 21 (60) 
Female 9 (56) 14 (40) 
Primary diagnosis (%)     
MAS 12 (75) 31 (89) 
PPHN 4 (25) 4 (11) 
Secondary diagnosis (%)     
PPHN 12 (75) 30 (86) 
Survival rate (%) 16 (100) 30 (86) 
     
Table 4.1 Patient characteristics. MAS: meconium aspiration 
syndrome. PPHN: persistent pulmonary hypertension of the 
neonate. * median values; ranges in brackets. † cases vs. 
controls: P = 0.01. 
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was initiated. Antibiotics were either 
geared to the micro-organism cul-
tured or discontinued when the cul-
tures remained negative and clinical 
signs of sepsis were absent. 
Data were analysed with the Fisher’s 
exact test and Mann-Whitney rank 
sum test where appropriate using a 
statistical computer program (SPSS 
7.5 for Windows). Differences were 
considered statistically significant 
when P <0.05. 
RESULTS 
In the study period, 96 neonates were treated with ECMO. To match for diagno-
sis, neonates from the parenterally fed group with the following diagnoses were 
excluded: congenital diaphragmatic hernia (n=17), pneumonia (n=4), blood as-
piration (n=2), lung hypoplasia (n=2), and other (n=4). After matching the fol-
lowing patients were excluded: five infants from the enterally fed group and nine 
infants from the parenterally fed group because of septic complications prior to 
ECMO, one infant because of surgery on ECMO and one infant who went off ECMO 
before nutrition had been started. Thus, sixteen cases and thirty-five controls 
were available for analysis. 
Gestational age, birth weight, sex, age and weight at initiation of the ECMO-run 
did not differ between cases and controls. The ECMO-run was significantly longer 
in the case group (median 161 versus 111 h, P = 0.01) (Table 4.1). All patients 
received vasoactive drugs, except for 2 controls (Table 4.2). Mortality was 0% in 
the case group versus 14% in the control group (P = 0.17). In two controls ECMO 
was discontinued after 3 and 4 days because of brain death. One patient with 
MAS died of relapsing pulmonary hypertension 10 days after decannulation. One 
patient with PPHN died 13 days after decannulation, shortly after operative cor-
rection of an atrial and ventricular septum defect and patent arterial duct. 
Autopsy findings were consistent with interstitial pneumonia, acute respiratory 
distress syndrome and pulmonary venous congestion. One patient with MAS died 
8 days after decannulation of massive intractable gastrointestinal bleeding, 7 
days after being transferred back to the referring hospital. 
Broad spectrum antibiotics were given to all neonates, most frequently amoxicillin 
in combination with cefotaxim (cases: 88%; controls: 89%). Other antibiotic 
combinations were penicillin and tobramycin (cases 12%; controls 3%), amoxicil-
lin and tobramycin (cases 0%; controls 5%), and amoxicillin and gentamicin 
(cases 0%; controls 3%). Enteral feedings were introduced 30 to 138 hours (me-
dian 67 h) after the initiation of ECMO. Highest intakes of enteral feeding ranged
 Cases (n) Controls (n) 
   
Dopamine 16 28 
Dobutamine 11 18 
Norepinephrin 10 7 
Epoprostenol 6 10 
NO-inhalation 8 6 
Isoprel 1 3 
Nitroprusside 0 1 
none 0 2 
   
Table 4.2 Use of inotropic and 
vasoactive drugs 
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from 1 to 15 mL/h (median 5 mL/h), and from 12 to 100 volume-% of nutrition 
intake (mean 47%). In three cases parenteral nutrition was stopped after 82 to 
178 h (median 104 h), because adequate enteral intake was reached. 
Gastric retention was observed in four patients in the case group. Owing to pro-
longed retention, enteral feeding had to be stopped in one patient. None of the 
patients received drugs to enhance gastric motility. Bloody stools or abdominal 
distension were never observed. 
Blood cultures became positive between 2 and 6 days after the initiation of ECMO. 
In both groups Coagulase-negative Staphylococci were cultured most frequently 
(Table 4.3). In the case group one Enterococcus was cultured during the septic 
episode. In the control group an Escherichia Coli was cultured during one septic 
episode and Coagulase-negative staphylococci during three episodes. There was 
no statistically significant difference in septic complications between the two 
groups (Table 4.4). 
DISCUSSION  
Intestinal integrity is thought to be instrumental in the immunological and micro-
bial barrier functions of the gastrointestinal tract.14,15 Both intestinal ischaemia 
and mucosal atrophy impair the mucosal barrier function, facilitate bacterial 
translocation, and may result in sepsis and, in premature infants, in necrotizing 
enterocolitis.6,7,16 
Enteral nutrition plays an important role in the maintenance of gut mucosal in-
tegrity. Several studies have shown that withholding enteral feeding leads to vil-
lous atrophy, decreased immunological function of the gut, increased gut mucosal 
permeability, and bacterial translocation, thereby favoring sepsis.6,8 In the criti-
cally ill, early initiation of enteral nutrition has been shown to restore intestinal 
mucosal integrity, even when only minimal quantities were given, whereas TPN 
has been associated with a persistent increase in gastrointestinal mucosal perme-
ability.6,8 Enteral nutrition has also been associated with improved gastrointestinal 
immunological function, reduced septic morbidity, and decreased cost.7,9 How-
ever, it has not yet been shown that 
enteral nutrition is superior to par-
enteral nutrition in critically ill pa-
tients with respect to outcome.7,9 
Given the hypoxic episodes before 
ECMO in a number of patients and 
the need for vasopressive drugs in 
the initial phase of ECMO, decreased 
intestinal blood flow and eventually 
intestinal ischaemia may occur. 
Hentschel et al., however, showed a 
significant rise of the mean arterial 
 Cases 
n (%) 
Controls 
n (%) 
     
No infection 12 (75) 24 (69) 
SIRS 2 (13) 2 (6) 
Bacteraemia 1 (6) 5 (14) 
Sepsis 1 (6) 4 (11) 
Total 16 (100) 35 (100) 
     
Table 4.4 Septic complications. SIRS: 
systemic inflammatory response syndrome. 
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pressure in the superior mesenteric artery in preterm infants when dopamine or 
dobutamine was administered.17 Others have shown an increase in intestinal 
blood flow after feeding.18,19 This suggests that vasopressors and enteral nutrition 
may have a beneficial effect on the splanchnic blood supply and gut mucosal in-
tegrity. 
Two studies have been published reporting the effects of enteral nutrition in 
ECMO patients. Our group, using urinary lactulose/rhamnose excretion to pro-
spectively assess small intestinal integrity in 16 consecutive neonatal ECMO pa-
tients, found intestinal integrity to be compromised in neonates on ECMO. Intro-
duction of enteral nutrition did not result in further deterioration.10 Pettignano et 
al conducted a chart review of 27 nonneonatal ECMO patients.20 The adequacy, 
tolerance, and complications of enteral nutrition were compared with those of 
parenteral nutrition. The investigators concluded that enteral nutrition can be 
administered safely. 
In the current study, the number of septic complications in neonates on ECMO 
was not affected by the type of nutritional support. Enteral nutrition was well tol-
erated and was not associated with any adverse effects. Our findings agree with 
those of Pettignano et al20 and extend his findings to the neonatal age. In both 
studies the number of infections in which gut mucosal integrity and bacterial 
translocation may have played a role was low. In the current study, Gram-nega-
tive bacteria were cultured three times, i.e. an equal incidence of 6% in both 
groups. Coagulase-negative staphylococci were the microorganisms cultured most 
frequently. Some may be the result of contamination, but we assume that in 
cases of sepsis these cultures were true-positive.21 To our knowledge, bactere-
mias with Coagulase-negative staphylococci have never been related to bacterial 
translocation. Studies that evaluate sepsis incidence in neonatal intensive care 
units show an increase of septic episodes and bacteremias due to Coagulase-
negative staphylococci, formerly considered nonpathogenic.21-24 This increase is 
thought to result from intensified use of vascular access techniques, such as 
ECMO cannulas and central venous catheters, by-passing the first defence against 
infection, the skin.23 
Several factors may explain that patients fed enterally were on ECMO longer than 
those fed parenterally. First, in 2 patients on parenteral nutrition ECMO was dis-
continued early because of brain death due to severe asphyxia before ECMO. 
Second, the proportion of PPHN-patients in the enteral group was higher than 
that in the parenteral group. Of PPHN patients approximately 83% survive vs. 
93% of MAS patients, and PPHN-patients generally need more time on ECMO than 
MAS-patients.1 A third explanatory factor may be the increasing complexity of 
cases over the years, associated with a decrease in survival.2 Kössel et al very 
recently pointed out that ECMO criteria for neonates pretreated with high fre-
quency oscillation and/or inhaled nitric oxide should be less strict than the ones 
commonly used.25 In the Netherlands, the use of high frequency oscillation and 
inhaled nitric oxide in the referring NICUs has increased gradually since 1996. 
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This makes the trend towards higher survival in the more recently treated enteral 
group observed in our study all the more interesting. Cases of necrotizing entero-
colitis were not observed, as might be expected in view of the small numbers of 
patients and their gestational age. 
The implications of the present study are limited by its design and patient num-
bers. In some patients enteral feedings were introduced fairly late in the course of 
ECMO, thereby potentially obscuring differences between feeding routes. Al-
though the ECMO protocol remained the same throughout the whole study period, 
minor changes of clinical practice may have resulted in differences between the 
controls -treated before 1996- and the cases -treated after 1995-, not related to 
the feeding route. Of 96 newborns on ECMO, fourty-five (47%) were excluded. 
Our findings, therefore, do not necessarily apply to all newborns on ECMO. 
The limitations imposed by patient numbers are best illustrated by taking our re-
sults and using them for a power analysis. Episodes of bacteraemia and sepsis, 
that is, episodes in which an infectious agent was identified, occurred in 12% of 
cases and 25% of controls (Table 4.4). A study aiming to demonstrate a reduc-
tion in infection rate from 25% to 12%, with alpha set at 0.05 and beta at 0.20 
(power 0.80), would require 125 patients in both groups. Even larger patient 
groups would be needed in order to identify differences with respect to gut-re-
lated infectious complications. Alternatively it might be argued that -under these 
conditions at least- bacterial translocation does not play the role it has formerly 
been attributed. 
In view of the number of neonates treated with ECMO worldwide, our results may 
serve as an incentive to perform prospective randomized studies that compare 
benefits of enteral and parenteral nutrition in neonates on ECMO. 
 Chapter 4 52
REFERENCES 
1. Stolar CJ, Snedecor SM, Bartlett RH. Extracorporeal membrane oxygenation and neo-
natal respiratory failure: experience from the extracorporeal life support organization. J 
Pediatr Surg 1991;26:563-71. 
2. Zwischenberger JB, Nguyen TT, Upp JR, Jr., et al. Complications of neonatal extracor-
poreal membrane oxygenation. Collective experience from the Extracorporeal Life Sup-
port Organization. J Thorac Cardiovasc Surg 1994;107:838-48; discussion 48-49. 
3. Anonymous. ECLS registry report - International summary July 1999. Ann Arbor (MI): 
Extracorporeal Life Support Organization; 1999 july 1999. 
4. Berseth CL. Minimal enteral feedings. Clin Perinatol 1995;22:195-205. 
5. Crissinger KD. Regulation of hemodynamics and oxygenation in developing intestine: 
insight into the pathogenesis of necrotizing enterocolitis. Acta Paediatr Suppl 
1994;396:8-10. 
6. Hadfield RJ, Sinclair DG, Houldsworth PE, Evans TW. Effects of enteral and parenteral 
nutrition on gut mucosal permeability in the critically ill. Am J Respir Crit Care Med 
1995;152:1545-8. 
7. Heyland DK, Cook DJ, Guyatt GH. Enteral nutrition in the critically ill patient: a critical 
review of the evidence. Intensive Care Med 1993;19:435-42. 
8. Okada Y, Klein N, van Saene HK, Pierro A. Small volumes of enteral feedings normalise 
immune function in infants receiving parenteral nutrition. J Pediatr Surg 1998;33:16-9. 
9. Lipman TO. Grains or veins: is enteral nutrition really better than parenteral nutrition? A 
look at the evidence. JPEN J Parenter Enteral Nutr 1998;22:167-82. 
10. Piena M, Albers MJ, Van Haard PM, Gischler S, Tibboel D. Introduction of enteral feeding 
in neonates on extracorporeal membrane oxygenation after evaluation of intestinal 
permeability changes. J Pediatr Surg 1998;33:30-4. 
11. Shew SB, Keshen TH, Jahoor F, Jaksic T. The determinants of protein catabolism in 
neonates on extracorporeal membrane oxygenation. J Pediatr Surg 1999;34:1086-90. 
12. Hayden WR. Sepsis terminology in pediatrics. J Pediatr 1994;124:657-8. 
13. Anonymous. American College of Chest Physicians/Society of Critical Care Medicine 
Consensus Conference: definitions for sepsis and organ failure and guidelines for the 
use of innovative therapies in sepsis. Crit Care Med 1992;20:864-74. 
14. Fink MP. Intestinal mucosal hyperpermeability in critical illness. In: Rombeau JL, Takala 
J, editors. Gut dysfunction in critical illness. Berlin Heidelberg New York: Springer-Ver-
lag; 1996. p. 12-24. 
15. Wells CL, Erlandsen SL. Bacterial translocation: intestinal epithelial permeability. In: 
Rombeau JL, Takala J, editors. Gut dysfunction in critical illness. Berlin Heidelberg New 
York: Springer-Verlag; 1996. p. 131-49. 
16. Sanderson IR. The physicochemical environment of the neonatal intestine. Am J Clin 
Nutr 1999;69:1028S-34S. 
17. Hentschel R, Hensel D, Brune T, Rabe H, Jorch G. Impact on blood pressure and intesti-
nal perfusion of dobutamine or dopamine in hypotensive preterm infants. Biol Neonate 
1995;68:318-24. 
18. Gladman G, Sims DG, Chiswick ML. Gastrointestinal blood flow velocity after the first 
feed. Arch Dis Child 1991;66:17-20. 
19. Maruyama K, Koizumi T, Tomomasa T, Morikawa A. Intestinal blood-flow velocity in 
uncomplicated preterm infants during the early neonatal period. Pediatr Radiol 
1999;29:472-7. 
Sepsis & ECMO 
 
53
20. Pettignano R, Heard M, Davis R, Labuz M, Hart M. Total enteral nutrition versus total 
parenteral nutrition during pediatric extracorporeal membrane oxygenation. Crit Care 
Med 1998;26:358-63. 
21. Baltimore RS. Is it real or is it a contaminant? A guide to the interpretation of blood 
culture results. Am J Dis Child 1987;141:241-2. 
22. Freeman J, Platt R, Sidebottom DG, Leclair JM, Epstein MF, Goldmann DA. Coagulase-
negative staphylococcal bacteremia in the changing neonatal intensive care unit popu-
lation. Is there an epidemic? JAMA 1987;258:2548-52. 
23. Freeman J, Epstein MF, Smith NE, Platt R, Sidebottom DG, Goldmann DA. Extra hospital 
stay and antibiotic usage with nosocomial coagulase-negative staphylococcal bactere-
mia in two neonatal intensive care unit populations. Am J Dis Child 1990;144:324-9. 
24. Gladstone IM, Ehrenkranz RA, Edberg SC, Baltimore RS. A ten-year review of neonatal 
sepsis and comparison with the previous fifty-year experience. Pediatr Infect Dis J 
1990;9:819-25. 
25. Kössel H, Bauer K, Kewitz G, Karaca S, Versmold H. Do we need new indications for 
ECMO in neonates pretreated with high-frequency ventilation and/or inhaled nitric ox-
ide. Intensive Care Med 2000;26:1489-95. 
 
 
  
5 Male sex predisposes the surgical newborn to 
parenteral nutrition-associated cholestasis and to 
sepsis 
 
 
 
 
 
 
 
 
 
 
 
Marcel J.I.J. Albers 
Dana-Anne H. de Gast-Bakker 
Nicolette A.M. van Dam 
Gerard C. Madern 
Dick Tibboel 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Arch Surg 2002;137:789-93 
 
 Chapter 5 56
ABSTRACT 
HYPOTHESIS: sepsis is an epiphenomenon of parenteral nutrition associated cho-
lestasis (PNAC) and not a causative factor; sepsis incidence is not affected by 
presence or absence of PNAC. 
DESIGN: observational cohort study. 
SETTING: pediatric surgery department in a tertiary referral children’s hospital. 
PATIENTS: newborns receiving PN for at least 7 days following intestinal surgery. 
MAIN OUTCOME MEASURES: PNAC criteria were: PN for at least 14 consecutive days, 
conjugated bilirubin level greater than 26 micromol/L, conjugated bilirubin frac-
tion greater than 50%, and absence of an other identifiable cause of cholestasis. 
The identification of septic events was based on Centers of Disease Control and 
Prevention criteria. 
RESULTS: The patients (26 with PNAC and 72 without PNAC) were well comparable 
with respect to underlying disease, gestational age, birth weight and age at the 
start of PN. Time receiving PN and length of hospital stay were significantly longer 
in patients with PNAC (P <0.001). PNAC was associated with male sex (P = 0.03; 
odds ratio 2.8, 95% confidence interval 1.1-7.1). Overall sepsis incidence was low 
(9 per 1000 hospital days). Sepsis incidence tended to be higher in patients with 
PNAC than in patients without PNAC (11.8 vs. 7.1 per 1000 days; P =0.08), but 
was significantly higher in male than in female patients (12.2 vs. 5.6 per 1000 
days; P =0.01). Most septic events was caused by coagulase-negative staphylo-
cocci. 
CONCLUSION: sepsis is an epiphenomenon of PNAC rather than a causative factor. 
Moreover, male sex predisposes the newborn surgical patient to PNAC and to 
sepsis. 
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INTRODUCTION 
Parenteral nutrition-associated cholestasis (PNAC) is a potentially life-threatening 
complication of parenteral nutrition (PN) seen in 7.4% to 84% of parenterally fed 
infants.1 Its aetiology is multifactorial; underlying disease, gestational age, birth 
weight, interval between birth and start of PN, PN duration, sepsis, remaining 
small bowel length and number of operative procedures have all been found to 
influence PNAC incidence.2-16 The identification of risk factors has been hampered 
by their interaction and the small size and heterogeneity of the populations de-
scribed in the majority of studies. The role of sepsis has remained especially con-
troversial. Although several authors suggest every attempt should be made to 
prevent sepsis because they believe it to be an important causative factor for 
PNAC,5,8,12,17,18 others have argued that the role of sepsis has been overempha-
sized or even that sepsis is an epiphenomenon of PNAC.2,8,19,20 
To assess the relation between sepsis and PNAC, we studied a homogeneous co-
hort of surgical newborns with a congenital or an acquired intestinal anomaly. We 
hypothesized that sepsis is an epiphenomenon of PNAC and that sepsis incidence 
would not be affected by presence or absence of PNAC. 
MATERIAL AND METHODS 
Clinical setting 
The Department of Pediatric Surgery forms part of a university tertiary referral 
children’s hospital serving a population of approximately 4.5 million. The pediatric 
surgical in-patient clinic consists of a 35-bed medium care unit and a 14-bed in-
tensive care and high care unit, annually admitting between 1600 and 1800 pa-
tients. Most are newborns and infants admitted because of congenital or neona-
tally acquired anomalies. The study period was from January 1, 1991, through 
December 31, 1996. During the study period the PN regimen and the antibiotic 
policy did not change. When PN was administered for more than a few days, as in 
our study population, a central venous catheter (Broviac catheter) was surgically 
introduced under general anesthesia. 
Parenteral nutrition 
Parenteral nutrition was provided according to hospital guidelines. Total PN pro-
vided 2.5 gram/kg per day of amino acids (Aminovenös N Paediatric; Fresenius 
AG, Bad Homburg, Germany) to newborns and 2.0 gram/kg per day of amino ac-
ids to older infants. Carbohydrates (Dextrose, Fresenius AG) provided approxi-
mately 65% and fat (Intralipid 20%; Pharmacia AB, Stockholm, Sweden) ap-
proximately 35% of non-protein calories. Enteral nutrition was introduced and 
advanced, and PN tapered as quickly as possible, based on stool output and 
weight gain. During tapering, the relative volumes of amino acids, lipids and car-
bohydrates in PN were kept within narrow limits. 
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Clinical data 
The hospital information system and the pharmacy’s PN registry were used to 
identify all newborns who required a surgical procedure and were receiving PN for 
7 or more days following surgery. The medical records were reviewed for patient 
characteristics and to identify cholestasis and septic events. Patient characteris-
tics included gestational age, sex, primary diagnosis, length of the hospital stay, 
age at the start of PN, days receiving PN, and outcome (alive or dead). Patients 
were included in our study if the primary reason for PN was an intrinsic intestinal 
anomaly. The diagnosis of PNAC was based on widely accepted clinical criteria: PN 
for at least 14 consecutive days, conjugated bilirubin level greater than 26 mi-
cromol/L, conjugated bilirubin fraction >50%, and absence of another identifiable 
cause of cholestasis.2,4-8,14,21 
Septic events 
The Centers for Disease Control and Prevention criteria for nosocomial infections 
were used to identify septic events.22 For septic events to be considered, positive 
blood culture results were mandatory. Primary and secondary bloodstream infec-
tions were grouped together as “sepsis”. If more than 1 microorganism was iden-
tified in 1 or more separate blood cultures taken on the same day, this was 
thought to reflect 1 septic event. Blood cultures taken on consecutive days and 
yielding different microorganisms were thought to reflect separate infections. 
Description and statistics 
Statistics were performed on a personal computer (Macintosh; Apple Computer, 
Inc, Cupertino, Calif) using a statistical software package (StatView, version 4.5; 
SAS Institute Inc, Cary, NC). Continuous data were analyzed using the t or Mann-
Whitney statistic, and are reported as mean ± 1 SD or median (range). Nominal 
data were analyzed using the Fisher’s exact statistic, unless otherwise noted. P 
<0.05 was considered statistically significant. 
 Patients 
with PNAC 
Patients 
without PNAC 
P 
    
Patients (n) 26 72  
Male-female ratio 17:9 29:43 0.03 
Gestational age (wk) 33.9 ± 4.0 34.7 ± 4.1 0.41 
Birth weight (g) 1979 ± 852 2085 ± 889 0.60 
Age at the start of PN (d) 3.5 (0-27) 5.0 (1-24) 0.19 
Time receiving PN (d) 46.5 (17-324) 24.5 (7-81) <0.001 
Length of the hospital stay (d) 66.5 (30-394) 41.0 (9-125) <0.001 
    
Table 5.1 Characteristics of patients with PNAC vs patients without PNAC 
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RESULTS 
In the 6-year study period, 123 newborns were given PN for 7 or more days 
following surgery. Twenty-five newborns were excluded because they did not 
have an intrinsic intestinal anomaly (congenital diaphragmatic hernia [n=13], 
isolated gastroschisis [n=6], omphalocele [n=2], bladder exstrophy [n=2], 
Ondine’s curse [n=1] and intracranial hemorrhage [n=1]). PNAC did not occur in 
any of the excluded patients. 
 
Parenteral nutrition-associated cholestasis was diagnosed in twenty-six of the 
ninety-eight newborns included in our study. It resolved before hospital discharge 
in nine patients, was still present at discharge in sixteen patients, and progressed 
to fatal liver failure in one patient. Patients with and without PNAC were very 
similar for gestational age, birth weight and age at the start of PN. Patients with 
PNAC were given PN significantly longer and stayed in the hospital significantly 
longer than patients without PNAC (Table 5.1). PNAC was associated with male 
sex (P = 0.03; Table 5.1 and Table 5.2); the odds ratio of PNAC occurring in male 
versus female newborns was 2.8 (95% confidence interval 1.1-7.1). These odds 
were not attributable to known differences between male and female patients. 
Indeed gestational age, birth weight, age at the start of PN, time on PN and 
length of hospital stay were all very similar in male and female newborns (Table 
5.2). 
Patient characteristics are summarized in Tables 5.1 and 5.2, and primary diag-
noses in Table 5.3. Of twenty-six patients with PNAC, two died; of seventy-two 
without PNAC, ten died (P = 0.51). In two patients without PNAC, death was 
closely related to a septic event. Overall, 51 septic events were identified in 
thirty-five patients. Sepsis was seen in thirteen (50 %) of the twenty-six patients 
who developed PNAC and in twenty-two (31 %) of the seventy-two without PNAC 
(P = 0.10). In eight (31 %) of the twenty-six patients with PNAC, sepsis had oc-
curred before PNAC was diagnosed. 
 Male Female P 
    
Patients (n) 46 52  
Ratio of patients with PNAC-
patients without PNAC 
17:29 9:43 0.03 
Gestational age (wk) 34.4 ± 3.9 34.5 ± 4.2 0.91 
Birth weight (g) 2059 ± 810 2056 ± 939 0.99 
Age at the start of PN (d) 4.0 (0-21) 6.0 (1-27) 0.11 
Time receiving PN (d) 31.5 (9-324) 29.5 (7-89) 0.43 
Length of the hospital stay (d) 50.0 (12-394) 44.0 (9-125) 0.62 
    
Table 5.2 Characteristics of male vs female patients 
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In view of the association between PNAC and male sex, we calculated sepsis inci-
dences for male and female patients with and without PNAC separately (Table 
5.4). An overall χ2 analysis yielded a P value of 0.03. Subsequently, all male pa-
tients were compared with all female patients, and all patients with PNAC were 
compared with all patients without PNAC. The incidence of sepsis was significantly 
higher in male patients than in female patients (P = 0.01) and tended to be 
higher in patients with PNAC than in patients without PNAC (P = 0.08) (P values 
not corrected for multiple comparisons). 
Most of the 56 microorganisms cultured during the 51 septic events were coagu-
lase-negative staphylococci (19 of 30 isolates in patients with PNAC and 18 of 26 
isolates in patients without PNAC [P = 0.78]). Other microorganisms isolated 
were as follows: Enterobacteriaceae (n=7), Enterococci (n=7), coliforms (n=3) 
and yeasts (n=2). On 5 occasions, 2 different microorganisms were identified on 
the same day and, therefore, held jointly responsible for one septic event. In one 
male PNAC patient, 2 consecutive septic events were only 2 days apart; other-
wise, the interval between 2 septic events in a patient was at least 1 week. 
DISCUSSION 
In a homogeneous group of surgical newborns with an intrinsic intestinal anom-
aly, we found male sex to be a predisposing factor for PNAC and for sepsis. To 
our knowledge, the association between male sex and PNAC has not been noted 
before. This may be because of the study designs, small patient numbers and the 
heterogeneity of the populations studied. Several studies aiming to identify PNAC 
risk factors were descriptive rather than comparative, did not discuss the sex dis-
tribution, or described a small or mixed medical-surgical population.2,3,5-7,9-15 
Ginn-Pease et al compared 16 surgical newborns with PNAC with 30 without PNAC 
and concluded that sex did not seem significant in the development of PNAC.4 Bos 
et al did not find a significantly different sex distribution between 15 surgical 
newborns with PNAC 
and 79 without 
PNAC.8 
Gestational age, birth 
weight, age when PN 
is started, and under-
lying disease affect 
the incidence of 
PNAC.2,4,5,12 In our 
study, these factors 
were similar in both 
groups. In keeping 
with previous studies, 
patients who devel-
 Patients 
with PNAC
Patients 
without PNAC 
Total 
    
Necrotizing enterocolitis 15 38 52 
Duodenal obstruction 3 17 20 
Meconium ileus and/or 
meconium peritonitis 
5 4 9 
Atresia    
small intestine 2 6 8 
esophagus 1 5 6 
Anorectal malformation 0 1 1 
    
Total 26 72 98 
    
Table 5.3 Primary diagnoses 
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oped PNAC were given PN longer than patients without PNAC and stayed in the 
hospital longer.2,4,12,17 Days receiving PN and length of hospital stay are often 
considered proxies for the severity of the underlying disease. The observed sex 
distribution might then ensue if the underlying disease would generally be more 
severe in male than in female patients. We are not aware of any such differences. 
Also, days receiving PN and length of hospital stay do not solely reflect the sever-
ity of disease but are the composite result of the severity of the underlying dis-
ease,14,23,24 the adverse effect of PNAC on intestinal function,25 and the adverse 
effects of disease-related and iatrogenic complications like septic events. Moreo-
ver, days receiving PN and length of hospital stay were similar in male compared 
with female patients and, therefore, do not explain the observed association be-
tween male sex and PNAC. 
An association between male sex and sepsis has recently also been demonstrated 
in adult surgical intensive care unit (ICU) patients. Wichmann found a signifi-
cantly higher incidence of severe sepsis in men when compared with women.26 
Similarly, male sex has been identified as a risk factor for nosocomial pneumonia 
in adult ICU patients.27 Furthermore, Hubacek et al recently demonstrated an as-
sociation between sepsis and common polymorphisms in the gene for lipopolysac-
charide-binding protein, a protein secreted into the bloodstream by hepatocytes 
that plays a crucial role in the modulation of lipopolysaccharide-induced cell re-
sponses in male, but not in female, ICU patients.28 We are not aware of similar 
data in pediatric surgical ICU patients. Animal experiments suggest the underly-
ing mechanism is a detrimental immunological effect of the male sex steroid tes-
tosterone or of low levels of female sex-steroids.29-31 Interestingly, these immu-
nological effects of sex steroids are reversed in older animals.32,33 
The relation between sepsis and PNAC is controversial. It has long been known 
that a severe bacterial infection may cause cholestatic jaundice in infants. It may 
be the only symptom of the infection, or precede it, and is completely reversible 
in those who survive.34 Jaundice accompanying bacterial infections has been de-
scribed in adults as well.35 In the study by Wichmann et al, male sex not only in-
creased the risk of severe sepsis but also the incidence of septic liver failure.26 
Interestingly, mortality was not influenced by sex,26 suggesting that in adult ICU 
patients septic liver failure is reversible too. 
 Male  Female  Total  
       
With PNAC 24/1679 (14.3) 3/613 (4.9) 27/2292 (11.8) † 
Without PNAC 12/1278 (9.4) 12/2079 (5.8) 24/3357 (7.1) † 
Total 36/2957 (12.2) * 15/2692 (5.6) * 51/5649 (9.0) 
       
Table 5.4 Sepsis incidence. Number of septic events per number of hospital days; sepsis 
incidence per 1000 hospital days between brackets. * P = 0.01; † P = 0.08. 
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Several,5,8,12,17,18 but not all,19,36 studies have shown that sepsis is seen in a 
larger proportion of patients with PNAC than in patients without PNAC, and con-
cluded that sepsis is a risk factor for PNAC. Most of these studies, however, did 
not account for differences in sex ratio or exposure time, i.e., length of stay, even 
though greater length of stay had previously been associated with PNAC.2,4 In 
effect, these studies were sepsis prevalence studies. When male and female pa-
tients are taken together, sepsis prevalence in our patients with PNAC was 50%, 
implying that PNAC occurred and progressed in 1 of 2 patients without the aid of 
a septic event. In only 1 of 3 did sepsis occur before PNAC was diagnosed. Sepsis 
incidence in patients with PNAC tended to be higher than that in patients without 
PNAC, but remained low (11.8 per 1000 hospital days, i.e., approximately 1 event 
in 3 months, versus 7.1 per 1000 hospital days). These incidences resemble 
those found by Sondheimer in 42 newborns on long term PN after neonatal intes-
tinal resection (approximately 10-12 per 1000 hospital days in patients with PNAC 
and 4 per 1000 hospital days in patients without PNAC).14 The overall sepsis inci-
dence in our study (9 per 1000 hospital days) was comparable to those recently 
found in surgical newborns37 and surgical patients of all pediatric ages (7.3 per 
1000 days in both studies).17 In the study by Sondheimer et al, the age at first 
infection was much lower in infants with PNAC than infants without PNAC and 
cholestasis developed relatively shortly after the first infection in 90% of the pa-
tients.14 Unfortunately, Sondheimer et al did not describe the sex distribution of 
their patients. Our data suggest that observed differences between patients with 
PNAC and patients without PNAC may depend on the number of male patients 
with PNAC. 
Whereas many researchers find sepsis an important risk factor for the initiation or 
progression of PNAC, some have taken a different view2,19 or argued that an in-
creased sepsis incidence is a consequence rather than a cause of PNAC.8,20 In our 
study, sepsis incidence was not increased in female patients with PNAC, and sep-
sis incidence was higher in male than in female patients, irrespective of the ab-
sence or presence of PNAC. Moreover, most septic events were caused by coagu-
lase-negative staphylococci. These infections are thought to result from vascular 
access techniques and, to our knowledge, have never been linked to intestinal 
pathological features.38 All these observations support the view that sepsis is an 
epiphenomenon of PNAC rather than a causative factor. 
Our observation that male sex predisposes the surgical newborn to PNAC and to 
sepsis may explain the association between sepsis and cholestasis found in other 
studies. If our findings are corroborated, they may have implications both for our 
understanding of the mechanism of disease and for the design of studies aiming 
to prevent or treat parenteral nutrition associated cholestasis. 
Sex, sepsis & cholestasis 
 
63
REFERENCES 
1. Kelly DA. Liver complications of pediatric parenteral nutrition - epidemiology. Nutrition 
1998;14:153-7. 
2. Pereira GR, Sherman MS, DiGiacomo J, Ziegler M, Roth K, Jacobowski D. Hyperalimen-
tation-induced cholestasis. Increased incidence and severity in premature infants. Am J 
Dis Child 1981;135:842-5. 
3. Hodes JE, Grosfeld JL, Weber TR, Schreiner RL, Fitzgerald JF, Mirkin LD. Hepatic failure 
in infants on total parenteral nutrition (TPN): clinical and histopathologic observations. J 
Pediatr Surg 1982;17:463-8. 
4. Ginn-Pease ME, Pantalos D, King DR. TPN-associated hyperbilirubinemia: a common 
problem in newborn surgical patients. J Pediatr Surg 1985;20:436-9. 
5. Bell RL, Ferry GD, Smith EO, et al. Total parenteral nutrition-related cholestasis in in-
fants. JPEN J Parenter Enteral Nutr 1986;10:356-9. 
6. Drongowski RA, Coran AG. An analysis of factors contributing to the development of 
total parenteral nutrition-induced cholestasis. JPEN J Parenter Enteral Nutr 1989;13: 
586-9. 
7. Spurr SG, Grylack LJ, Mehta NR. Hyperalimentation-associated neonatal cholestasis: 
effect of oral gentamicin. JPEN J Parenter Enteral Nutr 1989;13:633-6. 
8. Bos AP, Tibboel D, Hazebroek FW, Bergmeijer JH, van Kalsbeek EJ, Molenaar JC. Total 
parenteral nutrition associated cholestasis: a predisposing factor for sepsis in surgical 
neonates? Eur J Pediatr 1990;149:351-3. 
9. Nousia-Arvanitakis S, Angelopoulou-Sakadami N, Metroliou K. Complications associated 
with total parenteral nutrition in infants with short bowel syndrome. Hepatogastroen-
terology 1992;39:169-72. 
10. Moss RL, Das JB, Raffensperger JG. Total parenteral nutrition-associated cholestasis: 
clinical and histopathologic correlation. J Pediatr Surg 1993;28:1270-4; discussion 4-5. 
11. Jacquemin E, Maurage C, Borderon JC, Gold F, Laugier J, Rolland JC. Early cholestasis in 
premature infants receiving total parenteral nutrition: a possible consequence of shock 
and hypoxia. Eur J Pediatr Surg 1995;5:259-61. 
12. Beath SV, Davies P, Papadopoulou A, et al. Parenteral nutrition-related cholestasis in 
postsurgical neonates: multivariate analysis of risk factors. J Pediatr Surg 1996;31:604-
6. 
13. Moss RL, Das JB, Raffensperger JG. Necrotizing enterocolitis and total parenteral nutri-
tion-associated cholestasis. Nutrition 1996;12:340-3. 
14. Sondheimer JM, Asturias E, Cadnapaphornchai M. Infection and cholestasis in neonates 
with intestinal resection and long-term parenteral nutrition. J Pediatr Gastroenterol Nutr 
1998;27:131-7. 
15. Mayr JM, Schober PH, Weissensteiner U, Hollwarth ME. Morbidity and mortality of the 
short-bowel syndrome. Eur J Pediatr Surg 1999;9:231-5. 
16. Moss RL, Amii LA. New approaches to understanding the etiology and treatment of total 
parenteral nutrition-associated cholestasis. Semin Pediatr Surg 1999;8:140-7. 
17. Yeung CY, Lee HC, Huang FY, Wang CS. Sepsis during total parenteral nutrition: ex-
ploration of risk factors and determination of the effectiveness of peripherally inserted 
central venous catheters. Pediatr Infect Dis J 1998;17:135-42. 
18. Amii LA, Moss RL. Nutritional support of the pediatric surgical patient. Curr Opin Pediatr 
1999;11:237-40. 
19. Beale EF, Nelson RM, Bucciarelli RL, Donnelly WH, Eitzman DV. Intrahepatic cholestasis 
associated with parenteral nutrition in premature infants. Pediatrics 1979;64:342-7. 
 Chapter 5 64
20. Sondheimer JM, Cadnapaphornchai M, Sontag M, Zerbe GO. Predicting the duration of 
dependence on parenteral nutrition after neonatal intestinal resection. J Pediatr 1998; 
132:80-4. 
21. Teitelbaum DH, Han-Markey T, Schumacher RE. Treatment of parenteral nutrition-asso-
ciated cholestasis with cholecystokinin-octapeptide. J Pediatr Surg 1995;30:1082-5. 
22. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial 
infections, 1988 . Am J Infect Control 1988;16:128-40; erratum: Am J Infect Control 
1988;16(4):177. 
23. Carbonnel F, Cosnes J, Chevret S, et al. The role of anatomic factors in nutritional 
autonomy after extensive small bowel resection. JPEN J Parenter Enteral Nutr 1996;20: 
275-80. 
24. Kaufman SS, Loseke CA, Lupo JV, et al. Influence of bacterial overgrowth and intestinal 
inflammation on duration of parenteral nutrition in children with short bowel syndrome. 
J Pediatr 1997;131:356-61. 
25. Hofmann AF. Defective biliary secretion during total parenteral nutrition: probable 
mechanisms and possible solutions. J Pediatr Gastroenterol Nutr 1995;20:376-90. 
26. Wichmann MW, Inthorn D, Andress HJ, Schildberg FW. Incidence and mortality of se-
vere sepsis in surgical intensive care patients: the influence of patient gender on dis-
ease process and outcome. Intensive Care Med 2000;26:167-72. 
27. Kropec A, Schulgen G, Just H, Geiger K, Schumacher M, Daschner F. Scoring system for 
nosocomial pneumonia in ICUs. Intensive Care Med 1996;22:1155-61. 
28. Hubacek JA, Stuber F, Frohlich D, et al. Gene variants of the bactericidal/permeability 
increasing protein and lipopolysaccharide binding protein in sepsis patients: gender-
specific genetic predisposition to sepsis. Crit Care Med 2001;29:557-61. 
29. Wichmann MW, Ayala A, Chaudry IH. Male sex steroids are responsible for depressing 
macrophage immune function after trauma-hemorrhage. Am J Physiol 1997;273: 
C1335-40. 
30. Angele MK, Schwacha MG, Ayala A, Chaudry IH. Effect of gender and sex hormones on 
immune responses following shock. Shock 2000;14:81-90. 
31. Knöferl MW, Diodato MD, Angele MK, et al. Do female sex steroids adversely or benefi-
cially affect the depressed immune responses in males after trauma-hemorrhage? Arch 
Surg 2000;135:425-33. 
32. Kahlke V, Angele MK, Schwacha MG, et al. Reversal of sexual dimorphism in splenic T 
lymphocyte responses after trauma-hemorrhage with aging. Am J Physiol Cell Physiol 
2000;278:C509-16. 
33. Kahlke V, Angele MK, Ayala A, et al. Immune dysfunction following trauma-haemor-
rhage: influence of gender and age. Cytokine 2000;12:69-77. 
34. Hamilton JR, Sass-Kortsak A. Jaundice associated with severe bacterial infection in 
young infants. J Pediatr 1963;63:121-32. 
35. Jaundice due to bacterial infection. Gastroenterology 1979;77:362-74. 
36. Vileisis RA, Inwood RJ, Hunt CE. Prospective controlled study of parenteral nutrition-
associated cholestatic jaundice: effect of protein intake. J Pediatr 1980;96:893-7. 
37. Pierro A, van Saene HK, Donnell SC, et al. Microbial translocation in neonates and in-
fants receiving long-term parenteral nutrition. Arch Surg 1996;131:176-9. 
38. Freeman J, Epstein MF, Smith NE, Platt R, Sidebottom DG, Goldmann DA. Extra hospital 
stay and antibiotic usage with nosocomial coagulase-negative staphylococcal bactere-
mia in two neonatal intensive care unit populations. Am J Dis Child 1990;144:324-9. 
 
  
6 Clinical relevancy of nonurinary nitrogen excretion 
in newborns and infants after digestive tract 
surgery 
 
 
 
 
 
 
 
 
 
 
 
Marcel J.I.J. Albers 
Ewout W. Steyerberg 
Trinet Rietveld 
Dick Tibboel 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
JPEN J Parenter Enteral Nutr 2003;27:327-32 
 
 Chapter 6 
 
66
ABSTRACT 
BACKGROUND: Whether the contribution of nonurinary nitrogen excretion (N2NU) to 
total nitrogen excretion (N2TOT) is clinically relevant has not been tested in chil-
dren in an intensive care unit. Particularly after digestive tract surgery, fecal ni-
trogen losses, and losses via nasogastric tubes, enterostomies and wound drains 
may be large. 
METHODS: We prospectively measured urinary nitrogen excretion (N2U) and N2NU 4 
to 6 days after digestive tract surgery in 78 newborns and infants who were given 
total parenteral nutrition. 
RESULTS: Two hundred seven collections of excreta, each representing one 24-
hour period, were obtained. Median N2NU was 15 mg/kg/24 hours (range, 0.4-
153), median N2U 153 mg/kg/24 hours (range, 57-558), median N2TOT 179 
mg/kg/24 hours (range, 72-577), and the median ratio of N2NU and N2U 9.9% 
(range, 0.2-110). The observed variations could not be attributed to differences 
in the severity of the underlying disease or the surgical stress. The mean differ-
ence between N2TOT and N2U was 21 mg/kg/24 hours (95% prediction interval –
20 - +63). Use of a linear regression equation that predicts N2TOT according to 
N2U and the weights of other excreta eliminated bias and improved precision 
(95% prediction interval –34 - +34 mg/kg/24 hours). For individual measure-
ments, however, considerable imprecision remained. 
CONCLUSION: In newborns and infants, receiving parenteral nutrition 4 to 6 days 
after digestive tract surgery, N2NU is variable and not to be neglected. The only 
way to accurately assess total nitrogen excretion in individual patients is by 
measuring the nitrogen content of all excreta. 
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INTRODUCTION 
Catabolism and anabolism are fundamental aspects of illness and reconvales-
cence, often defined as whole-body nitrogen loss and whole-body nitrogen reten-
tion, or as a negative nitrogen balance and a positive nitrogen balance.1,2 Nitro-
gen balance studies therefore are one of the cornerstones of clinical nutrition re-
search. When assessing whole-body nitrogen excretion, urinary nitrogen excre-
tion (N2U) usually is measured or derived from urinary urea excretion. Nitrogen 
excretion via other routes (skin, stools, wounds, drains) is often assumed to be of 
minor importance or predictable.3-6 In children admitted to an intensive care unit 
(ICU), the value of urinary urea excretion as a predictor of N2U has been ques-
tioned.6-9 Whether nonurinary nitrogen excretion (N2NU) is of little importance 
when compared to N2U has not been tested in such children. N2NU may be par-
ticularly large after digestive tract surgery, when body fluids may be lost through 
nasogastric tubes, enterostomies, wound drains, and feces. We measured N2NU 
and N2U in newborns and infants in our pediatric surgical ICU who were receiving 
parenteral nutrition after digestive tract surgery and assessed the contribution of 
N2NU to total nitrogen excretion (N2TOT). 
MATERIAL AND METHODS 
Clinical setting 
Our pediatric surgical ICU is part of a tertiary referral university children’s hospi-
tal serving approximately 4.5 million inhabitants. At the time of the study, the 
ICU consisted of 2 essentially identical 7-bed units. Annually 600 to 700 patients 
were admitted for perioperative intensive and high care. The majority were new-
borns and infants admitted because of a congenital anomaly that required sur-
gery. The second most frequent reason for admission was postoperative intensive 
care in all pediatric age groups. 
Patients 
From January 1997 through December 1999, 80 newborns, infants, and children, 
admitted to our ICU after digestive tract surgery, entered a prospective trial that 
studied the effects of isonitrogenous enrichment of parenteral nutrition with glu-
tamine. As part of this trial, nitrogen excretion was measured on day 4, 5 and 6 
after surgery (day 0). 
The trial was approved by the institutional review board. Inclusion criteria were: 
gestational age > 30 weeks and age ≤ 1 month or gestational age ≥ 35 weeks 
and age ≤ 2 years, not expected to tolerate enteral nutrition for at least 4 days 
following digestive tract surgery, and written and signed informed parental con-
sent. Exclusion criteria were: simultaneous participation in another trial or previ-
ous participation in the current trial, preexistent renal or hepatic dysfunction that 
precluded the use of standard parenteral nutrition, an inborn error of metabolism, 
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an immunodeficiency or a disease that entailed impaired growth (other than dys-
maturity), the use of corticosteroid drugs, life expectancy <6 months (according 
to index diagnosis). The Pediatric Risk of Mortality II score (PRISM), obtained on 
the day of admission to the ICU, was used to assess the severity of illness.10 The 
Surgical Stress Score (SSS) was used as a proxy for the severity of the postop-
erative stress response.11 
Parenteral nutrition 
Total parenteral nutrition was started on day 2 after surgery. Depending on age 
and weight, it provided 85 to 100 kcal/kg/24 hours and 1.5 to 2.5 gram/kg/24 
hours of amino acids (Vaminolact®, Pharmacia, Stockholm, Sweden). Carbohy-
drates (dextrose, Fresenius, Bad Homburg, Germany) provided approximately 
65% of non-protein calories and fat (Intralipid® 20%, Pharmacia) approximately 
35%. If the patient’s condition and the surgical procedure would allow it, tapering 
of parenteral nutrition and reintroduction of enteral nutrition was started halfway 
through day 6. 
Excreta collection and laboratory analysis 
All excreta, with the exception of bronchopulmonary secretions and one patient’s 
decubitus wound exudate, were collected on day 4, 5 and 6 after surgery. For the 
collection of urine, a transurethral catheter was used, if present. In girls, if such a 
catheter was not being used already, it was inserted; for boys, appropriately 
sized urine bags were then used. Urine collection bags were emptied, and the 
collected volume was measured at least once every 4 hours. Leakage of urine 
that could not be quantified rendered that interval’s collection invalid (cf Appen-
dix). Collected urine was stored in a refrigerator in containers preacidified with 
sulfuric acid, until the morning of the next day, when it was transferred to the 
laboratory. Fluids produced through nasogastric or nasoduodenal tube drainage, 
feces, and enterostomy and wound drain output were also collected and stored in 
a refrigerator until transferal to the laboratory. Collection of these excreta was 
considered invalid if leakage was observed. 
In the laboratory, all collections were weighed and homogenized. Urine collections 
were further acidified with sulfuric acid to a pH of 2 to 4. An aliquot of every col-
lection was then stored at –20 °C until thawing and analysis. The total nitrogen 
content was determined by a continuous flow elemental analyzer (Carlo Erba NC-
1500; Interscience BV, The Netherlands). In brief, triplicate samples are weighed 
in tin sample containers, freeze-dried and combusted at 1020 °C. Copper reduces 
the formed nitrogen oxides to elemental nitrogen gas. The nitrogen gas flows 
through a thermal conductivity detector that generates an electrical signal pro-
portional to the concentration of nitrogen. This is an automation of the Dumas 
combustion method.12 
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Statistical analysis 
Beacause we intended to analyse the contribution of N2NU and N2U to N2TOT, the 
unit of analysis was 24-hour nitrogen excretion, with one to three 24-hour inter-
vals being available per patient. Nitrogen excretion was expressed as milligrams 
nitrogen per kilogram body weight per 24 hours. Values were reported as means 
± 1 SD or as medians with ranges. Values were reported only if the collections of 
all excreta were considered representative of the 24-hour interval in question and 
if other excreta than urine were produced. For the collected urine to be consid-
ered representative of the 24 hours in question, the total collection time had to 
equal at least 8 hours (cf Appendix).13 Collections of other excreta had to com-
prise all 24 hours to be considered representative. 
We analysed the relation between N2NU and N2U graphically by plotting N2NU ver-
sus N2U, and calculated the mean contribution of N2NU to N2TOT and a prediction 
interval of the contribution (mean ± 1.96 • SD). For our purpose, mean N2NU may 
be viewed as the bias resulting when N2U is measured instead of N2TOT, and the 
prediction interval as a measure of precision.14 We further compared measured 
N2TOT values with 2 sets of predicted N2TOT values. The first set consisted of the 
values predicted by a linear regression equation that used N2U as independent 
variable. The second set consisted of the values predicted by a linear regression 
equation that used N2U and the weights of other excreta (per kilogram body 
weight) as independent variables. All excreta were entered into this equation, 
provided 5 or more measurements were available. For both linear regression 
equations adjusted r2-values were reported, which take into account that the re-
gression models were estimated and tested on the same data. The difference 
between measured and predicted N2TOT (residual) was plotted against measured 
N2TOT to examine the effect of either regression equation on bias and precision. 
Standard descriptive and comparative statistics were calculated on a Macintosh 
computer (Apple Computer Inc, Cupertino, California, USA) using StatView ver-
sion 4.5 (SAS Institute Inc, Cary, NC, USA). A P value <0.05 was considered sta-
tistically significant. 
RESULTS 
Of 240 attempted 24-hour col-
lections, 25 were considered 
nonrepresentative and 8 con-
sisted of urine only, leaving 
207 collections, obtained in 
seventy-eight of the eighty 
patients included in the trial, 
for analysis. Patient charac-
teristics are summarized in 
Table 6.1. Fifty patients were
   
   
Weight (kg)   2.9 (1.0-10.9) 
Postnatal age (d)   8 (1-615) 
Pediatric risk of mortality score 10.5 (0-46) 
Surgical stress score 11 (6-17) 
   
Table 6.1 Patient characteristics (n = 78). 
Values are given as median (range). 
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operated on because of a congenital anomaly; twenty-eight because of an ac-
quired disease. The underlying diagnoses were necrotizing enterocolitis (n=18), 
duodenal obstruction (n=14), gastroschizis (n=7), small bowel atresia (n=7), 
Hirschsprung’s disease (n=7), other (n=25). Of 207 collections of excreta, 74 
were obtained on day 4, 67 on day 5, and 66 on day 6 after surgery. The total 
collection time for urine was 8 to 16 hours in 17 collections, 16 to 24 hours in 67 
collections and 24 hours in 123 collections. 
Nitrogen excretion values are summarized in Table 6.2. N2NU, N2U, and N2TOT all 
varied widely. The ratio between N2NU and N2U also varied widely: in 50% of all 
24-hour intervals, N2NU was <10% of N2U; but in 10% of all 24-hour intervals 
N2NU was >25% of N2U, with a maximum of 110% (Table 6.2). No correlation was 
found between N2NU and N2U (P = 0.71). Linear regression with N2U as independ-
ent variable and N2TOT as dependent variable resulted in the following equation 
(equation 1: adjusted r2 0.923): 
 
N2TOT = 19.9 + 1.01 • N2U 
 
Adding the weights (W) of other excreta as independent variables resulted in 
equation 2 (adjusted r2 0.945): 
 
N2TOT = 7.8 + 1.01 • N2U + 0.75 • W nasogastric drainage + 2.9 • W faeces + 
0.44 • W enterostomy output + 1.7 • W wound drain output 
 
Nasoduodenal fluid collections were not entered into equation 2 because only 3 
measurements were available. 
The mean difference (bias) between N2TOT and N2U was 21 mg/kg/24 hours, the 
95% prediction interval, –20 - +63 mg/kg/24 hours (Figure 6.1). By definition, 
both linear regression equations reduced the mean difference between measured 
and predicted N2TOT values to zero. Use of equation 1 did not affect the width of 
the prediction interval (95% prediction interval –41 - +41 mg/kg/24 hours; Fig-
ure 6.2 - upper panel), but use of Equation 2 did (95% prediction interval –34 - 
+34 mg/kg/24 hours; Figure 6.2 - lower panel). 
Multiple linear regression with PRISM and SSS as independent variables showed a 
small but statistically significant influence of PRISM and SSS on the logarithm of 
N2TOT (P <0.0001; r
2 = 0.09). No influence was detected on the ratio between 
N2NU and N2U (P=0.53). The Pearson correlation coefficient r between PRISM and 
SSS was 0.2, indicating that they may indeed be considered independent vari-
ables. 
The relation between the weight of the collected excreta and their nitrogen con-
tent, assessed separately for nasogastric tube drainage, feces, enterostomy, and 
wound drain output, was quite variable and seemed to be somewhat nonlinear 
(data not shown). 
 
  
Figure 6.1 N2NU was plotted on the vertical axis and N2U on the horizontal axis. Mean N2NU 
and the 95% prediction interval were indicated by solid and dashed horizontal lines. 
Figure 6.2 The difference between measured and predicted nitrogen excretion was plotted 
on the vertical axis and the measured nitrogen excretion on the horizontal axis. The mean 
difference and the 95% prediction interval were indicated by solid and dashed horizontal 
lines. Nitrogen excretion was predicted by: Equation 1 - upper panel; Equation 2 – lower 
panel (cf text). 
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DISCUSSION 
In a population of newborns and infants receiving parenteral nutrition 4 to 6 days 
after digestive tract surgery, we have shown N2NU and N2U, and their ratio, to 
vary widely. No correlation was found between N2NU and N2U. The observed 
variations in total nitrogen excretion and in the ratio between N2NU and N2U could 
only for a small part be attributed to the observed variations in the severity of the 
surgical stress or the underlying disease. 
Nitrogen intake minus nitrogen excretion constitutes the whole-body nitrogen 
balance. Especially if a patient is being fed parenterally, nitrogen intake can easily 
be calculated. Measuring nitrogen excretion, however, is an arduous task. In 
newborns and infants, acquiring accurate nitrogen excretion data is particularly 
difficult. The relatively small volumes of the excreta may result in relatively large 
effects of sampling and weighing errors. Critical illness, not having been toilet 
trained, and the use of urine bags may cause significant sampling errors and 
leakage. Although we preferred the use of transurethral catheters over urine 
bags, we felt we could not justify catheterization in boys solely for the purpose of 
this study because this procedure may cause urethral trauma.15 To avoid the 
leakage associated with the use of urine bags and long collection intervals, we 
modified the approach proposed by Boehm et al.13 In a population of low birth-
weight infants, they showed that a continuous 6-hour collection period suffices for 
metabolic monitoring purposes. Because our protocol did not insist on continuity 
of urine collection, we arbitrarily decided 8 hours to be the lower time limit of a 
representative urine collection. The majority of collection intervals (92%), how-
ever, comprised 16 to 24 hours. Because other excreta are not produced continu-
ously, these collections had to comprise the full 24-hour interval. 
Despite our efforts, sampling and weighing errors, particularly of urine or faeces, 
may have occurred. Such errors, though inherent to the clinical setting, would 
likely affect our precision but not necessarily bias our results. In this setting, vali-
dation of data is of paramount importance. However, the wide variation seen in 
daily nitrogen excretion, and the paucity of similar studies in comparable patient 
populations, make validation of our findings difficult. Still, other studies have 
found similarly wide variations of the daily N2U in surgical newborns
8 and infants3, 
pediatric ICU patients5, and healthy children.16 Chaloupecky et al studied thirty-
seven infants on the first day after cardiopulmonary bypass surgery and found 
N2U values averaging 235 ± 83 mg/kg/24 hours.
3 Helms et al found N2U in eight 
preterm newborns to be 209 ± 99 mg/kg/24 hours on day 1 to 3 after digestive 
tract surgery, and 96 ± 49 mg/kg/24 hours on day 7.8 In our study, N2U meas-
ured on day 4 to 6 after digestive tract surgery, was 169 ± 73 mg/kg/24 hours. 
Moreover, we found a small but significant influence of both SSS and PRISM on 
total nitrogen excretion. Our findings are in keeping with those of Chaloupecky et 
al and Helms et al and with the notion that nitrogen excretion in infants, as in 
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older children and adults, is proportional to the stress of surgery and to the stress 
imposed by the underlying disease, indicating that our findings are valid.1,17-19 
The limitations of the scoring systems should, however, be noted. SSS was origi-
nally designed by Anand and Ainsley-Green to grade the surgical stress of several 
types of surgery, including cardiopulmonary bypass surgery.11 When using SSS 
solely for digestive tract surgery, its range of potential values and its discrimina-
tive power are limited. Also, the effect of surgical stress on nitrogen excretion 
may have worn off by day 4 to 6 after surgery. Jones et al and Bouwmeester et al 
have shown that resting energy expenditure and (nor)epinephrine levels in new-
born patients normalize within 24 hours after surgery.20,21 Nitrogen excretion in 
surgical newborns may parallel resting energy expenditure as it does in adults.1 
PRISM II has been validated for use in the Netherlands, but its performance as a 
predictor of mortality in surgical patients was not as good as that in nonsurgical 
patients.22,23 PRISM II should be obtained on the day of first admission to the 
ICU, which occasionally preceded inclusion into this study by several days or even 
weeks. More importantly, PRISM predicts mortality risk and as such does not al-
ways reflect the severity of illness.24 These limitations, and the wide intrinsic 
variation in nitrogen excretion discussed earlier, may explain why SSS and PRISM 
had only small effects on total nitrogen excretion. 
We are not aware of any data on N2NU in populations comparable to the one in 
our study. As a rule, nonurinary nitrogen loss is neglected or accounted for by a 
formula that converts urinary urea or urinary nitrogen excretion to total nitrogen 
excretion.3-6 In one textbook on paediatric intensive care, fecal nitrogen loss is 
said to equal 20% of urinary excretion, but a reference is not given, precluding 
identification of the population the original data apply to.2 In a study by Ziegler et 
al in 123 normal children aged 1 to 11 years, fecal nitrogen excretion averaged 
15% of N2U.
16 In our study, fecal nitrogen excretion was 10 ± 15 % of urinary 
excretion (data not shown), and nitrogen excretion through all excreta other than 
urine equaled 14 ± 15 % of urinary excretion. It should be noted that our pa-
tients were fed parenterally, which would likely yield a lower stool output when 
compared with a general pediatric ICU population.6 
Measuring nitrogen excretion in newborns and infants is difficult and laborious, as 
was mentioned earlier. For this reason, we, and others before us, have tried to 
find equations that derive N2TOT from easily-obtainable parameters. Because uri-
nary urea content does not reliably predict urinary nitrogen content in critically ill 
children6-9 and because urine generally is the main route of nitrogen excretion, 
we used measured N2U as the basis of our equations. On average, measured N2U 
underestimated N2TOT by 21 mg/kg/24 hours (Figure 6.1). Adding this fixed 
amount, or a fixed percentage (in our study, 14%; Table 6.2) to measured (uri-
nary) nitrogen excretion is the approach others have followed in different set-
tings.2,4,25 Whereas this approach reduces bias, it does not improve precision. 
Similarly, using a linear regression equation will, by definition, eliminate bias, but 
not necessarily improve precision, as is illustrated by equation 1 (Figure 6.2 – up-
Urinary & nonurinary nitrogen excretion 
 
75
per panel). Equation 2, on the other hand, by incorporating the weights of ex-
creta, did improve precision (Figure 6.2 – lower panel). We chose to use these 
weights because they are easy to obtain and often are obtained as part of stan-
dard patient care. Although equation 2 may suffice for group comparisons, con-
siderable imprecision remained for individual patient assessment, which could 
only be avoided by measuring the nitrogen content of all excreta. Also, when de-
ciding whether to use equation 2, the clinician should bear in mind that the re-
sulting loss of precision is added to that of sampling and weighing of excreta. 
Ideally, external validation should be performed first to assess whether the re-
gression coefficients apply to other settings and case mixes. 
In conclusion, N2NU is variable and not to be neglected when assessing total ni-
trogen excretion in newborns and infants receiving parenteral nutrition shortly 
after digestive tract surgery. Although relatively simple predictive equations may 
yield reasonable estimates, the only way to accurately assess total nitrogen ex-
cretion is by measuring the nitrogen content of all excreta. 
APPENDIX: URINE COLLECTION 
Urine collection bags were emptied and the collected volume (VCU) was measured 
at least once every 4 hours. At the time of emptying, the tared diapers were 
reweighed to check for quantifiable urine leakage and the bedding was inspected 
for (nonquantifiable) leakage. The presence of any nonquantifiable leakage ren-
dered the corresponding interval’s urine collection invalid. That interval’s collected 
urine would then be discarded. If all leakage was quantifiable, the weight of 
quantifiable urine leakage was converted to volume (VQUL) using a conversion 
factor of 1 g/mL. Leakage was assumed to have occurred at random. Urine, col-
lected in the interval between emptyings (I), thus represents the fraction of that 
interval defined by 
 
I • VCU/(VCU+VQUL). 
 
The total volume of urine collected over 24 hours represents a total collection 
time equal to the sum of the fractions of the intervals 
 
∑ [ I • VCU/(VCU+VQUL)]. 
 
Twenty-four hour N2U was calculated by multiplying the nitrogen content of the 
collected urine by 
 
24 / ∑ [ I • VCU/(VCU+VQUL)]. 
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ABSTRACT 
OBJECTIVE: To assess the effect of isocaloric isonitrogenous parenteral glutamine 
supplementation on intestinal permeability and nitrogen loss in newborns and in-
fants after major digestive tract surgery. 
SUMMARY BACKGROUND DATA: Glutamine supplementation in critically ill and surgical 
adults may normalise intestinal permeability, attenuate nitrogen loss, improve 
survival and lower the incidence of nosocomial infections. Previous studies in criti-
cally ill children were limited to very low birthweight infants and had equivocal 
results. 
METHODS: 80 newborns and infants were included in a double-blind, randomized 
trial, comparing standard parenteral nutrition (sPN; n=39) to glutamine-supple-
mented parenteral nutrition (GlnPN; glutamine target-intake 0.4 g•kg-1•day-1; 
n=41), starting on day 2 after major digestive tract surgery. Primary endpoints 
were intestinal permeability, as assessed by the urinary excretion ratio of lactu-
lose and rhamnose (week 1 through 4); nitrogen balance (day 4 through 6), and 
urinary 3-methylhistidine excretion (day 5). Secondary endpoints were mortality, 
length of stay in the ICU and the hospital, number of septic episodes, and usage 
of antibiotics and ICU resources. 
RESULTS: Glutamine intake plateaued at 90% of the target on day 4. No differ-
ences were found between patients assigned sPN and patients assigned GlnPN 
regarding any of the endpoints. Glutamine supplementation was not associated 
with adverse effects. 
CONCLUSIONS: In newborns and infants after major digestive tract surgery, we did 
not identify beneficial effects of isonitrogenous, isocaloric glutamine supplemen-
tation of parenteral nutrition. Glutamine supplementation in these patients 
therefore is not warranted. 
Glutamine & parenteral nutrition 
 
81
INTRODUCTION 
Glutamine is the most abundant free amino acid of the body and has many es-
sential metabolic functions. During critical illness, demands are increased and 
may not be met by endogenous supply and dietary intake.1 In critically ill adults, 
placebo-controlled randomized studies have shown that glutamine supplementa-
tion normalises intestinal permeability, attenuates nitrogen losses, and enhances 
immunological defenses against infection.1-7 Related clinical effects include im-
proved survival, a lower incidence of infections, shorter hospital stay, and lower 
ICU and hospital costs.1,3,5,8,9 Placebo-controlled randomized studies in critically ill 
children have so far been limited to very low birth weight infants.10-13 Lacey et al 
studied 78 preterm infants, and concluded that parenteral glutamine reduced the 
time on total parenteral nutrition and on the mechanical ventilator, and acceler-
ated the transition to full enteral feeding in a subgroup of infants weighing less 
than 800 grams.10 Neu et al studied 67 very low birth weight infants and con-
cluded that enteral glutamine lowered the incidence of sepsis, improved the toler-
ance to enteral feeding, and lowered hospital costs.11,14 A subsequent multi-cen-
ter trial in 649 very low birth weight infants, however, failed to show an effect of 
enteral glutamine on the incidence of blood-culture proven nosocomial sepsis.13 
We hypothesized that glutamine supplementation might be of benefit to newborns 
and infants who needed intensive care and parenteral nutrition after major diges-
tive tract surgery. The primary endpoints of this study are the effect of isocaloric 
isonitrogenous parenteral glutamine supplementation on intestinal permeability 
and nitrogen loss in this population. 
MATERIALS AND METHODS 
Study outline 
The study protocol was approved by the institutional review board. The study was 
designed as a double-blind randomised controlled trial. In newborns and infants 
who needed intensive care after digestive tract surgery, we compared standard 
parenteral nutrition (sPN) with isonitrogenous, isocaloric, glutamine-supple-
mented parenteral nutrition (GlnPN). The primary endpoints of the study were 
intestinal permeability, as measured by sugar absorption tests; nitrogen balance; 
and urinary 3-methylhistidine (3MH) excretion. Secondary endpoints were mor-
tality and morbidity. Measures of morbidity assessed were: length of ICU stay and 
length of hospital stay; number of septic episodes; usage of antibiotics; usage of 
ICU resources, as assessed by the therapeutic intervention scoring system – 76 
(TISS); and renal and hepatic damage, as assessed by renal and liver function 
tests. 
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Patients 
Our pediatric surgical ICU is part of a tertiary referral university children’s hospi-
tal. Provided informed parental consent was obtained, patients admitted to our 
ICU were enrolled if they fullfilled all of the inclusion criteria and none of the ex-
clusion criteria. The inclusion criteria were: gestational age >30 weeks and age 
≤2 years; not expected to tolerate enteral nutrition for at least 4 days following 
digestive tract surgery. Exclusion criteria were: simultaneous participation in an-
other trial or previous participation in the current trial; preexistent renal or he-
patic dysfunction that precluded the use of standard parenteral nutrition; an in-
born error of metabolism; an immunodeficiency or a disease that entailed im-
paired growth (other than dysmaturity); the use of corticosteroid drugs; preexis-
tent life expectancy less than 6 months. 
Baseline data included demographic data, index diagnosis, operative procedure 
and the Pediatric Risk of Mortality II score (PRISM) and Surgical Stress Score 
(SSS). PRISM, obtained on the day of admission to the ICU, was used to assess 
the severity of illness,15 and SSS to assess the severity of the post-operative 
stress response.16 
Stratification, randomization, blinding 
The patients were divided into four strata according to age: I - gestational age 
≥30 weeks and post-conceptional age <37 weeks; II - post-conceptional age ≥37 
weeks and age ≤0.5 year; III - age >0.5 and ≤1 years; IV - age >1 and ≤2 
years. We used a computer-generated randomisation schedule to assign patients 
sPN or GlnPN. Patients were randomized blockwise in groups of four. The ran-
domisation schedule was made available only to the pharmacist that supervised 
the processing of parenteral nutrition. Glutamine-enriched and standard nutrition 
bags were labeled identically. All physicians and nurses involved in the patients' 
care were blinded to nutrition assignments. 
Parenteral nutrition 
On a daily basis, parenteral nutrition was custom-made for each patient. A two-
bag system was used, with one bag containing amino acids (Vaminolact®, Phar-
macia, Sweden), carbohydrates (Dextrose, Fresenius, Bad Homburg, Germany), 
minerals, trace elements, carnitene, water-soluble vitamins and water; and the 
other bag containing lipids (Intralipid® 20%, Pharmacia, Stockholm, Sweden) and 
fat-soluble vitamins. Total parenteral nutrition was started on day 2 after surgery 
(designated day 0), according to hospital guidelines, stating that amino acid and 
lipid intake start at approximately 50% of the recommended intake in the first 24 
hours of parenteral feeding and reach the recommended intake in the following 
24 hours. Depending on weight, recommended intakes were 1.5-2.5 gram/kg/24h 
of amino acids and 85-100 kcal/kg/24h, with carbohydrates providing approxi-
mately 65% of non-protein calories and fat approximately 35%. Provided the pa-
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tient’s condition and the surgical procedure would allow it, tapering of parenteral 
nutrition and reintroduction of enteral nutrition was started on or after day 6. 
Parenteral nutrition was withheld once patients received more than 75-80% of 
the recommended intake via the enteral route. If patients needed to revert to 
parenteral feeding, they were assigned the same parenteral nutrition (sPN or 
GlnPN) as before. If patients were still being fed parenterally at day 31, the study 
nutrition would be replaced by standard parenteral nutrition. 
L-glutamine was purchased as a 2.5% solution in sterile water from Oxford Nutri-
tion (Oxford, UK) and stored at –20 ˚C. Isonitrogenous isocaloric supplementa-
tion was achieved by substituting predefined volumes of amino acids and water 
with L-glutamine. Based on a study by Allen 17, we aimed to administer 0.4 gram 
of glutamine per kilogram body weight per day to patients fully dependent on 
parenteral nutrition. Parenteral glutamine intake and non-protein caloric intake 
were calculated in the same fashion as nitrogen intake (see below). 
Sugar absorption tests 
A sugar absorption test was performed on the fifth day of the 1st through 4th week 
after surgery, unless the patient had already been discharged from the hospital. 
The test solution was prepared by the hospital pharmacy. One hundred and forty 
milligrams of glucose, 140 mg of rhamnose, and 70 mg of xylose were dissolved 
in 50 mL demineralized water, 8.6 g of lactulose was added, and demineralized 
water was added up to a total volume of 100 mL. Patients were given 1 mL of this 
solution per kilogram body weight, via nasogastric tube. Urine, passed in the next 
4 hours, was collected; if the collection failed, the test was repeated once within 
the next 24 hours. One mL was frozen at –80 ˚C until thawing and analysis. We 
have described the details of the analytical procedure elsewhere.18 The sugars’ 
urinary excretions were expressed as a percentage of the dose ingested and the 
lactulose-rhamnose ratio as the ratio of these percentages. 
Nitrogen balance 
Nitrogen balance data were acquired on day 4, 5 and 6. The nitrogen excretion 
data were also used to study the contribution of nonurinary nitrogen loss to total 
nitrogen loss, and have recently been published.19 All excreta, with the exception 
of bronchopulmonary secretions and one patient’s decubitus wound exudate, 
were collected, stored and analysed.19 Nitrogen intake was calculated as the 
product of the volumes and the nitrogen contents of the administered amino acid 
solutions. The nitrogen content was calculated for each solution separately, based 
on the product information and the patients’ parenteral nutrition datasheets. Ni-
trogen balance was calculated as the difference between nitrogen intake and ni-
trogen excretion and expressed as milligrams nitrogen per kilogram body weight 
per 24 hours. 
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Urinary 3-methylhistidine excretion 
An aliquot of the urine collected on day 5 was used to calculate 3MH excretion. 
Urinary 3MH content was measured by ion exchange chromatography on a Bio-
chrome 20 amino acid analyser with ninhydrin detection (Biochrome, Cambridge, 
UK). Twenty-four hour urinary 3MH excretion was calculated in the same fashion 
as 24-hour urinary nitrogen excretion,19 and expressed as micromols per kilogram 
body weight per day. The urinary 3MH-creatinine ratio was expressed as micro-
mol per mmol. 
Fullfilled inclusion criteria 108 
Randomised 80 
Excluded 28 
  3 prior inclusion 
25 no parental consent 
Withdrawn 1 
Discharged 8 
Discharged 7 
Discharged 3 Discharged 4 
Discharged 6 
Discharged 8 
Successful data acquisition: 
sugar absorption 28/38 
nitrogen balance 37/38 
3-MH excretion 33/38 
3-MH-creatinine ratio 34/38 
Successful data acquisition: 
sugar absorption 34/41 
nitrogen balance 40/41 
3-MH excretion 36/41 
3-MH-creatinine ratio 36/41 
Successful data acquisition: 
sugar absorption 20/30 
Successful data acquisition: 
sugar absorption 26/35 
Successful data acquisition: 
sugar absorption 19/23 
Successful data acquisition: 
sugar absorption 24/27 
Successful data acquisition: 
sugar absorption 14/20 
Successful data acquisition: 
sugar absorption 16/23 
Standard PN 39 Glutamine-supplemented PN 41 
Day 4-6 
Day 12 
Day 19 
Day 26 
Figure 7.2 Flow chart including primary endpoints. PN: parenteral nutrition. 3-MH: 3-
methylhistidine. 
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Mortality, length of stay in the ICU and in the hospital 
A distinction was made between 31-day mortality, i.e. mortality during the inter-
val that the study nutrition was used as parenteral nutrition; and all-cause in-
hospital mortality. Length of stay in the ICU and in the hospital was expressed in 
days, and calculated as the difference between the date of discharge and the start 
of surgery. 
Septic episodes, antibiotic usage 
The Centers for Disease Control and Prevention criteria for nosocomial infections 
were used to identify septic events.20 For septic events to be taken into account, 
positive blood cultures were mandatory. Primary and secondary bloodstream in-
fections were grouped together as ‘sepsis’. Standard 48-hour perioperative anti-
biotic prophylaxis consisted of amoxicillin and cefotaxime or cefoxitin and to-
bramycin, depending on age. Conversion to a therapeutic regimen was based on 
the underlying disease and the intraoperative findings. Empirical therapy for 
nosocomial infections was directed by hospital guidelines. During the study period 
the antibiotic policy did not change. As part of standard patient care, medication 
prescription data were entered into the hospital information system by the hos-
pital pharmacy. We retrieved this data to calculate the number of antibiotic doses 
prescribed to each trial patient on each day, from day 0 through day 31. 
TISS 
As part of standard ICU patient care, TISS data were prospectively entered into 
the hospital information system by the ICU nurses, during each night shift.21 We 
retrieved the TISS data for each patient, from day 0 through day 31. A TISS 
score of 0 (zero) was assigned each day a patient was not in the ICU. As a result 
of a problem with electronic storage of TISS data in the hospital information sys-
tem, not all TISS data were retrievable. We did not attempt to reconstruct miss-
ing data, but analysed the data that were available. 
Renal and liver function tests 
Serum urea and creatinine were determined on day 4 through 6, and on day 7 of 
the 2nd through 4th week after surgery; total and direct bilirubin, aspartate and 
alanine aminotransferases, gamma-glutamyltransferase, alkaline phosphatase, 
lactate dehydrogenase and ammonia were determined on day 7 of the 1st through 
4th week. Blood samples were not taken if the patient did not receive any par-
enteral nutrition. 
Statistical analyses 
Normal lactulose-rhamnose ratios in newborns and infants are approximately 
0.05 ± 0.02 (mean ± 1 SD).22 With two-sided tests, α = 0.05 and β = 0.20, we 
calculated that inclusion of 80 patients should allow us to detect a between-group 
difference of 0.015. At the time the study was planned, nitrogen balance and 3MH 
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excretion data were not available for similar populations of surgical infants. Power 
calculations were therefore restricted to lactulose-rhamnose ratios. 
Analyses were by intention-to-treat. Differences in development over time in the 
two treatment groups were analyzed with repeated-measures analysis of variance 
(ANOVA proc mixed, v8.2, SAS Institute Inc, Cary NC, USA). We used random 
intercept models that allowed inclusion of all available data. The models com-
prised main effects of treatment and time and the interaction between treatment 
and time. Time was included as a factor with a number of levels equal to the 
maximum number of measurements available per subject, to account for possible 
non-linearities over time. Sugar absorption data were log-transformed before 
analysis, because of a skewed distribution. All other analyses were performed 
with StatView (v4.5, SAS Institute Inc, Cary NC, USA). In view of the relatively 
small patient numbers, we did not perform subgroup analyses. A P value <0.05 
was considered statistically significant. 
RESULTS 
From January 1, 1997, through December 31, 1999, one hundred and eight new-
borns and infants met the inclusion criteria (Figure 7.1). Three patients were ex-
cluded because they had participated in the trial before. In twenty-five patients, 
parental consent was not obtained. Of the eighty patients randomised, thirty-nine 
were assigned sPN and fourty-one were assigned GlnPN. One of the patients as-
signed sPN was withdrawn from the study on day 3 when it became obvious that 
enteral feeding would be tolerated. 
Baseline data are summarized in Table 7.1. Fifty patients required surgery be-
Parenteral nutrition Standard Glutamine-
   
Patients 39 41 
male:female 27:12 25:16 
Stratum   
I gestational age ≥ 30 weeks and 
post-conceptional age < 37 weeks 
13 12 
II post-conceptional age ≥ 37 weeks 
and age ≤0.5 years 
22 22 
III age > 0.5 years and ≤ 1 year 2 4 
IV age > 1 year and ≤ 2 years 2 3 
Weight in kg, median (IQR)  3.0 (2.1 – 3.8) 2.8 (2.1 – 3.6) 
Age in days, median (IQR) 14 (2.3 – 54) 8 (2.8 - 94) 
PRISM, median (IQR)  11 (7 – 17) 9 (6 – 16) 
SSS, median (IQR)  11 (9 – 13) 11 (9 – 13) 
   
Table 7.1 Baseline data. IQR: interquartile range. PRISM: Pediatric Risk of Mortality score. 
SSS: Surgical Stress Score. 
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cause of a congenital digestive tract anomaly (sPN 24, GlnPN 26), and thirty pa-
tients because of an acquired anomaly (sPN 15, GlnPN 15). The major diagnostic 
categories were: necrotizing enterocolitis (n=19), duodenal obstruction (n=14), 
gastroschizis (n=7), small bowel atresia (n=7), Hirschsprung’s disease (n=7), 
other (n=26). Demographic data, PRISM, SSS, and nitrogen and caloric intake in 
the first week after surgery of patients receiving sPN and of those receiving GlnPN 
were similar (Table 7.1, Figure 7.2). Glutamine intake reached a plateau of well 
over 90% of the target (0.4 g•kg-1•day-1) on day 4 (Figure 7.2). In univariate 
analyses we found no relation between PRISM or SSS and glutamine intake. Ca-
loric intake also reached a plateau on day 4, of approximately 80% of the target 
(Figure 7.2). 
Primary endpoints 
In patients assigned sPN 81 of 111 planned tests succeeded (73%) and in pa-
tients assigned GlnPN 100 of 126 tests succeeded (79%; Figure 7.1). Repeated-
measures analysis showed that the urinary excretion ratio of lactulose and rham-
nose (Table 7.2) and the excretion of any of the four sugars tested (data not 
shown) did not differ between study groups at any time after surgery. 
Nitrogen excretion data were acquired in thirty-seven patients assigned sPN and 
in fourty patients assigned GlnPN (Figure 7.1). Overall, 76 valid collections of ex-
creta were obtained on day 4, 68 on day 5, and 68 on day 6. Repeated-measures 
analysis of variance did not show significant differences between the nitrogen bal-
ance data of sPN and GlnPN patients (Table 7.2). 
3MH-creatinine excretion ratios were obtained in thirty-four sPN patients and 
thirty-six GlnPN patients. In one sPN patient, urine volume was not measured re-
liably, so that 24-hour 3MH excretion was determined only in thirty-three sPN pa-
 SPN (n=38) GlnPN (n=41) P 
    
Lactulose-rhamnose ratio (%/%)   0.11 * 
Day   5 0.142 (0.044-0.228) 0.093 (0.024-0.150)  
Day 12 0.096 (0.067-0.160) 0.087 (0.050-0.239)  
Day 19 0.083 (0.022-0.106) 0.080 (0.057-0.137)  
Day 26 0.069 (0.025-0.139) 0.071 (0.041-0.104)  
Nitrogen balance (mg/kg/24h)   0.89 * 
Day   4 150 (63-197) 141 (61-207)  
Day   5 154 (61-198) 160 (87-204)  
Day   6 136 (72-264) 164 (63-205)  
3MH excretion (µmol/kg/24h) 4.0 (2.7-4.7) 3.2 (2.9-3.8) 0.08 † 
3MH-creatinine ratio (µmol/mmol) 47 (36-65) 44 (37-56) 0.42 † 
    
Table 7.2 Primary endpoints. All values are given as medians with interquartile ranges 
between brackets. 3MH: 3-methylhistidine * Repeated measures analysis of variance. 
† Mann-Whitney U statistic. 
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tients (Figure 7.1). Twenty-four hour 3MH excretion was higher in sPN patients 
than in GlnPN patients, but the difference was not statistically significant (Table 
7.2). The 3MH-creatinine ratios did not differ significantly (Table 7.2). 
In univariate analyses, both PRISM and SSS exerted a statistically significant, but 
small influence on nitrogen excretion and nitrogen balance (P <0.01; r2 ≤ 0.09 
for all analyses), but not on nitrogen intake and the 3MH-creatinine excretion ra-
tio. We also found a statistically significant inverse correlation between nitrogen 
balance and the 3MH-creatinine ratio (P = 0.015; r2 = 0.084). 
Secondary endpoints 
We found a similar thirty-one day mortality rate, length of stay in the ICU and 
length of stay in the hospital in the two groups (Table 7.3). Two patients in the 
GlnPN group died after the first month, i.e. after the period of study nutrition. 
In thirty-eight sPN patients, 6 culture-proven septic episodes were identified from 
day 1 through 31 after surgery, and 9 in fourty-one GlnPN patients (P = 0.53; 
Table 7.3). The number of antibiotic dosages prescribed was very similar in the 
two groups (Table 7.3). Cumulative TISS scores were retrieved in thirty-two pa-
tients assigned sPN, and in thirty-seven patients assigned GlnPN. Cumulative 
TISS scores did not differ between groups (Table 7.3; Figure 7.3). Repeated-
measures analysis of variance also did not show significant differences of the 
TISS scores between groups. With the exception of ammonia, laboratory tests did 
not reveal any differences between the two groups at any point in time (data not 
shown). Repeated measures analysis of ammonia data showed a small, but sta-
tistically significant, difference between patients assigned sPN and those assigned 
GlnPN (overall median 34 versus 44 micromol/L; Table 7.3), and between points 
in time (data not shown). 
 SPN (n=38) GlnPN (n=41) P 
    
Deaths (n)    
Day 0 – 31 0 0 - 
All cause in-hospital 0 2 0.16 § 
Length of stay in the ICU (days) 9,5 (4,5-23) 8,0 (4-20) 0.57 † 
Length of stay in the hospital (days) 31,5 (14-64) 32 (16,8-44,8) 0.80 † 
Septic episodes Day 0 – 31 (n) 6 9 0.53 § 
Cumulative antibiotic dosages Day 0 – 31 30 (20-58) 35 (16–62) 0.75 † 
Cumulative TISS Day 0 - 31 119 (44-222) 93 (64-218) 0.82 † 
Serum ammonia (micromoL/L) 34 (28–50) 44 (35–59) 0.008 * 
    
Table 7.3 Secondary endpoints. All values are given as medians with interquartile ranges 
between brackets, unless otherwise noted. † Mann-Whitney U statistic. * Repeated measures 
analysis of variance, group comparison. § χ2 test. 
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DISCUSSION 
In a population of newborns and infants, receiving parenteral nutrition after major 
digestive tract surgery, isonitrogenous isocaloric glutamine supplementation of 
parenteral nutrition did not affect intestinal permeability or nitrogen balance. 
Mortality, length of ICU and hospital stay, and usage of antibiotics and ICU re-
sources, also were not affected. We did not identify adverse effects of parenteral 
glutamine supplementation. 
 
A recent systematic review of glutamine supplementation in critically ill and surgi-
cal adults concluded that the greatest benefit was to be expected when glutamine 
was administered parenterally, in doses higher than 0.20 g•kg-1•day-1.1 Whether 
critically ill children might benefit from glutamine, and what dose would be neces-
sary to realise potential benefits, has not been established yet.12,13,23 We planned 
to administer a parenteral glutamine dose of 0.4 g•kg-1•day-1, the highest dose 
tried in critically ill infants.12,13 Because of the study design, further increasing the 
dose of glutamine would have implied further lowering the amount of essential 
and other amino acids provided. Within two days after starting parenteral nutri-
tion (four days after surgery), we realised a parenteral glutamine intake of 0.36 
g•kg-1•day-1. Realised intake did not depend on the severity of the surgical stress 
or of the underlying disease. Parenteral nitrogen intake also plateaued at ap-
proximately 90% of the target, and caloric intake at approximately 80%. Al-
though nitrogen intake did not equal the high recommended daily allowance for 
low-birthweight infants, some of which were included in our study, nitrogen re-
tention approached intrauterine rates.24,25 Caloric intake equaled or exceeded the 
expected total energy expenditure.26,27 In our opinion, achieved daily intakes 
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Figure 7.2 Intake of nitrogen (left panel) and non-protein calories (right panel) on day 2 to 
6 after surgery, as a percentage of the target (mean ± SEM). Open circles: patients 
assigned sPN; closed circles: patients assigned GlnPN. Note that, in patients assigned 
GlnPN, nitrogen intake values equal glutamine intake values. 
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should have allowed glutamine supplementation to have an effect. Cumulative 
intake of glutamine may however have been too low, as studies in adults suggest 
that glutamine may exert its effects only after a minimum of five to six days of 
supplementation.1,28 In the present study, tapering of parenteral nutrition, and 
therefore of glutamine intake, was allowed to start on day 6, i.e. 2 days after a 
satisfactory glutamine intake had been reached. Thus, the isonitrogenous design 
of this study -and of most other studies- may obscure potential benefits of glu-
tamine supplementation by limiting the intake of glutamine and of essential and 
other amino acids.29 
The choice which patients to feed parenterally, and how to taper parenteral feed-
ing, is closely linked to the type of surgical procedure, and based on clinical 
judgement. We realise that the potential effects of glutamine supplementation 
may be obscured by loose criteria for parenteral nutrition, and that parenteral 
nutrition should be used cautiously in ICU patients.30 In particular, some might 
prefer transanastomotic tube feeding for patients with a congenital foregut anom-
aly. This, however, is not standard practice, and we were not willing to accept the 
risks of transanastomotic feeding. 
SSS and PRISM served as a calibration of the severity of the surgical stress and 
the underlying disease. SSS in most of our patients was higher than 8, i.e. in the 
range labeled “major surgery” in relation to the observed stress response in new-
borns.27 PRISM in our patients 
was high in comparison with 
values observed in surgical pa-
tients in a Dutch PRISM valida-
tion study.31 The infants we 
included suffered from diverse 
surgical conditions and under-
went diverse surgical proce-
dures, and thus constituted a 
heterogeneous population. The 
included patients do however 
mirror the pediatric surgical 
ICU population. 
 
In adults, increased intestinal 
permeability has been ob-
served in association with sep-
sis and organ dysfunction, and 
after two weeks of standard, 
but not glutamine-supple-
mented, parenteral nutri-
tion.1,4,32 In newborns older 
than two days, normal 
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Figure 7.3. Cumulative TISS (mean ± SEM) from 
day 0 through 31 after surgery. Open circles: pa-
tients assigned sPN; closed circles: patients assigned 
GlnPN. Note that patients discharged from the ICU 
have a daily TISS of zero. 
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intestinal permeability is not related to gestational age or birth weight.33 We have 
previously reported increased intestinal permeability in critically ill preterm infants 
operated because of necrotizing enterocolitis.18 Permeability normalized in several 
of these infants, even though total parenteral nutrition was continued for three 
weeks.18 In newborns on extracorporeal membrane oxygenation, we found 
intestinal permeability to be increased, irrespective of whether they received 
parenteral or enteral nutrition.34 In the present study, lactulose-rhamnose ratios 
remained elevated for up to four weeks in the majority of patients. Also, intestinal 
permeability in patients who received total parenteral nutrition was not 
statistically different from that in patients who received enteral nutrition (data not 
shown). These findings suggest that not parenteral nutrition per se, but rather 
the underlying disease, alone or in combination with surgery, causes increased 
intestinal permeability. 
Resting energy expenditure and (nor)epinephrine levels in newborn patients in-
crease in response to the stress of surgery, but normalize again within 24 
hours.27,35 Preterm infants may retain nitrogen in the first seventy-two hours after 
surgery.36 In the present study, the severity of the surgical stress and the under-
lying disease had limited effects on nitrogen excretion and nitrogen balance, and 
most patients retained adequate amounts of nitrogen on day 4 to 6.24 These 
findings add to the evidence that the stress response in young infants may be 
short-lived. Nevertheless, the urinary 3MH-creatinine ratio and 3MH excretion 
were increased, suggesting increased breakdown of muscle protein.37 Increased 
breakdown of muscle protein in the face of nitrogen retention may indicate re-
routing of nitrogen fluxes for wound healing, or for the defense against infec-
tion.38 Alternatively, persistently increased breakdown of muscle protein might be 
accompanied by increased synthesis and thus reflect increased turnover, and not 
loss of muscle protein. 
 
In adults with systemic inflammatory response syndrome, enteral glutamine sup-
plementation reduced the number of nosocomial infections, even though nitrogen 
balance and intestinal permeability were not different.9 In very-low-birthweight-
children however, the rate of suspected and culture-proven nosocomial sepsis 
was not affected by enteral glutamine supplementation.13 In our population, 
parenteral glutamine supplementation did not change the incidence of culture-
proven sepsis. We also analysed antibiotic usage and cumulative TISS scores, 
because we argued that a reduction of the rate or severity of any infection, not 
just sepsis, would be clinically relevant if it resulted in reduced usage of 
antibiotics or resources. We found no difference in antibiotic usage between 
groups, and no difference in TISS. TISS does not assess resource usage outside 
the ICU. Nonetheless, we did not demonstrate an effect of glutamine supple-
mentation on ICU resource usage. 
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Studies in critically ill adults and children suggest that glutamine supplementation 
is safe.1,10,11,13,39-41 We found no difference in 31-day mortality between patients 
assigned sPN or GlnPN. Two in-hospital deaths occurred in the group assigned 
GlnPN, but only after the study nutrition had been replaced with standard par-
enteral nutrition. Glutamine supplementation is unlikely to have played a role in 
these deaths. It should be noted that our study was not designed to detect differ-
ences in mortality. As mortality in pediatric surgical intensive care populations 
generally is very low, this would have required a very large trial.31 Serum ammo-
nia was higher in glutamine-supplemented infants, but the difference was not 
clinically relevant (Table 7.3). 
 
In view of the promising results in adults, more research into the effects of glu-
tamine supplementation in infants and children seems justified.23,29 Currently 
however, our findings suggest that parenteral glutamine supplementation for sur-
gical infants is not warranted. 
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SUMMARY 
In the setting of critical illness, major surgery and poor gastrointestinal function, 
the choice how to provide nutritional support is delicate. This thesis describes 
studies on nutritional support in newborns and infants who required surgical 
treatment for diseases entailing poor gastrointestinal function. 
In Chapter 2 we compared the urinary excretion ratios of enterally administered 
lactulose and rhamnose -a measure of intestinal permeability- obtained in thir-
teen preterm newborns who underwent surgery because of necrotizing enteroco-
litis, with those obtained in ten newborns who underwent surgery for other rea-
sons. In patients with necrotizing enterocolitis, intestinal hyperpermeability gen-
erally persisted throughout the first week after surgery. In some patients, intesti-
nal permeability started to normalise in the second to third week after surgery, 
whereas in others hyperpermeability persisted throughout the third week. In-
creases of intestinal permeability occurring in the second or third week after sur-
gery coincided with episodes of sepsis and bowel obstruction. In control patients, 
intestinal permeability started to normalise in the first week after surgery. We 
concluded that intestinal hyperpermeability persisting beyond the first week after 
surgery should be attributed to the underlying disease, i.e. to necrotizing entero-
colitis. Customising the (re)introduction of enteral nutrition seemed justified, but 
should not be based solely upon the lactulose-rhamnose ratio. 
In Chapter 3 we used the same measure of intestinal permeability, combined 
with measures of carrier-mediated transport, in newborns treated with extracor-
poreal membrane oxygenation. We compared seven patients who received enteral 
nutrition with nine patients who received total parenteral nutrition. In thirteen of 
these sixteen patients, intestinal permeability was increased. Urinary D-xylose 
excretion, a measure of passive carrier-mediated transport, was normal in both 
groups of patients. Urinary 3-O-methyl-D-glucose excretion, a measure of active 
carrier-mediated transport, was decreased in both groups of patients and did not 
differ between the two groups. Neither the lactulose-rhamnose excretion ratios, 
nor any of the other parameters, changed after introduction of enteral nutrition. 
We concluded that intestinal permeability and transport were compromised in all 
patients, irrespective of feeding route, and that the introduction of enteral nutri-
tion did not result in further deterioration. Our findings did not support the clinical 
practice of withholding enteral nutrition from patients treated with extracorporeal 
membrane oxygenation. 
In Chapter 4 we assessed the effect of the route of feeding on the incidence of 
septic complications in newborns treated with extracorporeal membrane oxy-
genation. The frequency of septic complications observed in sixteen patients re-
ceiving enteral nutrition did not differ from that observed in thirty-five patients 
receiving total parenteral nutrition, even though extracorporeal membrane oxy-
genation lasted longer in the group of patients receiving enteral nutrition. Of 11 
septic complications in which a microorganism was identified, 8 were caused by 
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coagulase-negative staphylococci. Therefore, they were considered not to be re-
lated to intestinal integrity, but to the use of central venous catheters and arterial 
and venous cannulas. We did not identify adverse effects of enteral nutrition. We 
once more concluded that our findings did not support the withholding of enteral 
nutrition from newborns treated with extracorporeal membrane oxygenation. 
In Chapter 5 we described a cohort of newborns with an intrinsic intestinal 
anomaly who received parenteral nutrition for at least 7 days following surgery. 
We compared the incidence of sepsis in twenty-six patients who developed par-
enteral nutrition-associated cholestasis with that in seventy-two patients who 
didn’t. Although the incidence of sepsis was somewhat higher in patients who did 
develop cholestasis than in patients who didn’t, overall sepsis incidence was low 
(9 per 1000 hospital days). Of the 56 microorganisms that were cultured, 37 
were coagulase-negative staphylococci. As noted earlier, infections caused by 
these microorganisms are thought to be related to vascular access techniques, 
and not to intestinal pathology. Parenteral nutrition-associated cholestasis oc-
curred and progressed without a septic event in thirteen out of twenty-six pa-
tients. Both sepsis and cholestasis occurred more frequently in male than in fe-
male newborns. We concluded that sepsis is an epiphenomenon of parenteral nu-
trition-associated cholestasis rather than a causative factor. 
In Chapter 6 we compared the contribution of nonurinary nitrogen excretion and 
urinary nitrogen excretion to total nitrogen excretion in seventy-eight newborns 
and infants who were receiving total parenteral nutrition 4 to 6 days after gas-
trointestinal surgery. Both nonurinary and urinary nitrogen excretion, and their 
ratio, varied widely. Relatively simple predictive equations yielded reasonable es-
timates of nonurinary nitrogen excretion, but considerable imprecision remained 
in individual measurements. We concluded that nonurinary nitrogen excretion 
should not be neglected, and that total nitrogen excretion could only be accu-
rately assessed in the individual patient by measuring the nitrogen content of all 
excreta. 
In Chapter 7 we described the effects of isonitrogenous isocaloric glutamine sup-
plementation of parenteral nutrition in newborns and infants who underwent ma-
jor gastrointestinal surgery. In a double-blind randomized controlled trial, we 
compared fourty-one patients who received glutamine-supplemented parenteral 
nutrition with thirty-nine patients who received standard parenteral nutrition. In 
most patients, intestinal permeability was increased after surgery and remained 
increased during the study period. Glutamine supplementation did not have a 
measurable effect on intestinal permeability, nitrogen balance, the incidence of 
septic events, and usage of antibiotics and ICU resources, nor did it affect mor-
tality and length of ICU and hospital stay. We did not identify any beneficial effect 
of glutamine supplementation of total parenteral nutrition, and concluded it was 
not warranted in these patients. 
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DISCUSSION 
There is growing consensus that critically ill medical and surgical patients may 
benefit from nutritional support and that the gastrointestinal tract should be used 
for nutritional support whenever possible.1-8 The focus of nutritional research in 
critically ill adults has shifted to the potential benefits of early compared with de-
layed enteral nutrition.7,9 Likewise, in pediatric ICU patients, how best to provide 
enteral nutrition now seems to be the main topic of interest.10-14 Nonetheless, one 
meta-analysis in surgical and critically ill adults and two recent randomised pro-
spective trials in adults, one of them including patients with severe sepsis, sug-
gest parenteral nutrition may be superior to enteral nutrition in selected groups of 
patients.5,15,16 In one of these trials, 41% of 562 adults were deemed to have a 
functioning gastrointestinal tract, and were therefore given enteral nutrition by 
the attending physican. Permanent or temporary intestinal failure was diagnosed 
in 48% of patients, who were then given total parenteral nutrition. In 11% of 
patients, there was doubt as to the adequacy of gastrointestinal function; the 
authors concluded that this subgroup should also be given parenteral nutrition.5 
Fewer than 6% of the subgroup of non-surgical patients required total parenteral 
nutrition, versus 55% of postoperative patients.5 In a recent retrospective study 
of ninety-five pediatric ICU patients, seventeen of whom had undergone gastro-
intestinal surgery (orthotopic liver transplantation), fifty-six patients were given 
nutritional support: fourty-six patients (82%) received enteral nutrition, seven 
patients (13%) received total parenteral nutrition, and three patients (5%) re-
ceived a combination of parenteral and enteral nutrition.8 These data illustrate 
that enteral nutrition may not always be superior to parenteral nutrition, and that 
a substantial number of patients are being given parenteral nutrition. Also of 
note, the decision that gastrointestinal function was “adequate”, and that par-
enteral nutrition was not required, was based solely on clinical experience.5 
 
Poor function and non-function of the gastrointestinal tract constitute indications 
for parenteral nutrition.1 Within the context of critical illness, gastrointestinal 
function has been ill-defined. Emphasis has been put on the barrier function of 
the gastrointestinal tract, because of the association of increased intestinal per-
meability with severity of disease, ‘gut-derived’ sepsis and multiple organ fail-
ure.17,18 Intestinal permeability itself, however, is a complex notion, and hyper-
permeability to molecular probes, such as lactulose and rhamnose, is not neces-
sarily associated with increased permeability to bacteria or bacterial prod-
ucts.7,19,20 The reverse may also hold true: after the second day of life, intestinal 
permeability to molecular probes in enterally fed preterm neonates did not differ 
from that of healthy term neonates,21 but advancing enteral feedings in preterm 
neonates was found to increase the incidence of necrotizing enterocolitis when 
compared to minimal enteral feeding.22 The findings we presented in Chapter 2 
through 4 of this thesis lend further support to the idea that intestinal perme-
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ability is multifaceted. In Chapter 2 we showed that intestinal hyperpermeability 
may persist throughout the third week of necrotizing enterocolitis. Yet, restarting 
enteral feeding after a median of 4 days from the onset of necrotizing enterocoli-
tis has been associated with significant benefits and no apparent adverse effects, 
when compared to restarting after 10 days.23 In Chapter 3 and Chapter 4 we 
showed that enteral nutrition was well tolerated by a group of critically ill term 
neonates treated with extracorporeal membrane oxygenation, and not associated 
with adverse effects, even though intestinal permeability to molecular probes was 
increased and these neonates were at risk for intestinal ischemia. Irrespective of 
feeding route, active carrier-mediated transport over the intestinal wall was also 
affected, whereas passive carrier-mediated transport in these patients was nor-
mal, again attesting to the complexity of gastrointestinal permeability. It is also 
apparent from these data that markers of intestinal permeability like the ones 
used in Chapter 2 and Chapter 3 are of little or no help in deciding whether or 
not to provide enteral nutrition to critically ill patients. 
 
Enteral nutrition had no measurable effect on intestinal permeability in the criti-
cally ill neonates described in Chapter 3 and Chapter 4, but has been shown to 
normalise intestinal permeability to molecular probes in other ICU patients.7 
Moreover, as was shown in parenterally fed surgical infants, small volumes of 
enteral nutriton may suffice to normalise immune function, and by doing so, im-
prove gut barrier function.24 In postoperative cardiac surgery patients with circu-
latory compromise, enteral nutrition may increase cardiac index and splanchnic 
blood flow.25 These and other effects of the presence of nutrients in the gut lumen 
may be regarded as what constitutes the difference between parenteral nutrition 
and total parenteral nutrition. 
Many of the complications of parenteral nutrition, however, occur in patients who 
receive a combination of enteral and parenteral nutrition. These complications 
therefore are related to the composition of the parenteral mixture, to the way it is 
administered, to the disease or condition for which parenteral nutrition support is 
required, or to a combination of the aforementioned. The composition of par-
enteral nutrition has traditionally been determined on the basis of recommended 
daily allowances of macronutrients and micronutrients, and potential toxicity of 
individual constituents.26 More recently, the concept of immunonutrition or phar-
maconutrition has been introduced to delineate non-nutritive effects of specific 
nutrients. The awareness that certain nutrients, when supplied to the right pa-
tients at the right time and in the right, frequently supraphysiological, doses, may 
favourably affect the immune response, has resulted in several prospective trials 
that explored the potential benefits of these nutrients.27 Promising results in adult 
patients undergoing surgery28,29 have been offset by the finding that enteral 
immunonutrition containing arginine increases mortality in critically ill adults.16,28 
Glutamine has been added to enteral as well as parenteral mixtures, and has 
been associated with beneficial effects.29 A recent meta-analysis concluded that a 
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benefit from glutamine may exist for surgical and critically ill adults, but that 
these two groups should be studied separately to decide whether these effects 
are clinically relevant.29 The findings we presented in Chapter 7 should be viewed 
in this light. Whereas we did not identify beneficial effects of parenteral glutamine 
supplementation in surgical infants, further research is needed to discriminate 
potential effects on the response to surgery from effects on the underlying dis-
ease. 
 
The study described in Chapter 7 serves to illustrate another issue pertinent to 
the complications of parenteral nutrition. In keeping with other studies, use of the 
parenteral route made it possible to realise a nitrogen and caloric intake close to 
the predefined target. Enteral nutrition, on the other hand, frequently results in 
intakes far below target.3,5,6,8,14 Target intakes in our study and in many other 
studies, were based on recommended daily allowances for healthy individuals, 
and were not adapted to critical illness or individual requirements, because the 
relevant guidelines are not available. Measurements of energy expenditure in 
children after gastrointestinal and cardiopulmonary bypass surgery and in pedia-
tric ICU patients and children with sepsis and systemic inflammatory response 
syndrome, have yielded values lower than or equal to those observed in normal 
children.30-34 Furthermore, considerable variability of energy expenditure exists 
within these populations.31,33-35 In Chapter 6 we found nonurinary, urinary and 
total nitrogen excretion to vary widely in surgical infants receiving total parenteral 
nutrition. These findings corroborate earlier studies in children that found 
postoperative nitrogen balance to vary widely, and lend further support to the 
notion that nutritional requirements show large variations between 
individuals.36,37 
From these joint observations it follows that overfeeding is likely to occur in criti-
cally ill children and is even more likely to occur if nutritional support is given via 
the parenteral route. Symptoms of overfeeding critically ill patients include hy-
perglycemia.38 Hyperglycemia is part of the metabolic response to critical illness 
and major surgery, but is also more common in adult ICU patients receiving par-
enteral nutrition than in those receiving enteral nutrition.39 In adult diabetics, 
postoperative hyperglycemia has been associated with a five-fold increased rate 
of nosocomial infections,40 and in surgical ICU patients, strict control of blood glu-
cose levels with insulin dramatically reduced ICU and in-hospital mortality, largely 
because of a lower incidence of sepsis-induced multiple organ failure.41 Although 
in one trial lowering the amount of calories provided as parenteral nutriton did 
not reduce the incidence of hyperglycemia and infections,42 some have argued 
that trials demonstrating beneficial effects of enteral nutrition in ICU patients 
were poorly-controlled and in fact demonstrated the deleterious effects of over-
feeding and hyperglycemia in patients receiving parenteral nutrition.43 Several 
studies in pediatric ICU patients have documented symptoms that may be indica-
tive of overfeeding, notably high respiratory quotients obtained by indirect calo-
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rimetry.31,34,35 However, these data have not been analysed with the aim to pro-
vide insight in the incidence and severity of overfeeding or hyperglycemia in pedi-
atric ICU patients in relation to the route of nutrition. One of the main reasons 
analyses like these have not been done may be the lack of readily applicable, 
sensitive techniques to assess the nutritional status of critically ill children and 
short-term changes of this status.44,45 
 
Sepsis is a potentially life-threatening complication for all patients receiving par-
enteral nutrition. In the setting of critical illness (Chapter 4) as well as in the 
setting of long-term parenteral nutrition (Chapter 5), we found the majority of 
septic events to be caused by coagulase-negative staphylococci. Bloodstream in-
fections by coagulase-negative staphylococi are closely related to the use of cen-
tral venous catheters.46,47 Catheter-related bloodstream infections, in turn, are 
among the leading causes of nosocomial infections in intensive care units.46,48,49 
Infection-prevention guidelines and catheter insertion and maintenance protocols 
have been shown to lower the rate of catheter-related infections in critically ill 
patients and in patients who receive parenteral nutrition.46,48,50 Our findings un-
derscore the importance of strict adherence to these guidelines and protocols. 
 
Parenteral nutrition-associated cholestasis may over time develop into terminal 
liver failure and thereby is a potentially life-threatening complication for patients 
who remain dependent on parenteral nutrition for months or years. The relation 
of sepsis and parenteral nutrition-associated cholestasis has been discussed in 
Chapter 5. The finding that sex affects the incidence of sepsis in infants receiving 
parenteral nutrition, however, merits discussion in a broader context. As dis-
cussed in Chapter 5, male sex has been identified as a risk factor for sepsis and 
nosocomial pneumonia in adult ICU patients.51,52 In adults, the age-related sepsis 
mortality rates for men are slightly higher than for women, but these differences 
are explained by differences in comorbidity and site of infection.53 A recent survey 
of severe pediatric sepsis found the incidence and the mortality rate of sepsis to 
be higher in male than in female infants.54 In children aged 1 to 9 years, the inci-
dence of sepsis was higher in boys than girls, but mortality rates were similar.54 
These findings should be taken into account when interpreting the findings of 
studies on nutrition and gastrointestinal function in the setting of critical illness 
and major surgery; particularly when the numbers of patients included are small, 
which often is the case, sex and age distribution inequalities may heavily influ-
ence the results. 
 
One of the first patients to benefit from parenteral nutrition was an infant with an 
intestinal anomaly.55 Today, parenteral nutrition still is of vital importance to the 
care of infants with a poor or non-functioning gastrointestinal tract. Over the 
years, the use of parenteral nutrition has become increasingly safe, and new in-
sights and vascular access techniques are likely to make it even safer. Still, the 
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complications associated with the use of parenteral nutrition are well-defined and 
potentially life-threatening. The use of enteral nutrition, though generally consid-
ered feasible, safe and less costly, is not without complications either. Particularly 
in the setting of poor gastrointestinal function, major surgery and critical illness, 
the decision how to provide nutritional support may be difficult. Gastrointestinal 
function has so far proved too complex to identify easily applicable, sensitive 
markers that help the clinician make this decision. For lack of randomised trials 
on nutritional support in surgical infants, clinical experience remains the basis of 
decision-making. Clinical experience, however, has not always been a good coun-
sellor, and much more fundamental and clinical research are needed to arrive at 
nutritional support strategies for surgical infants that meet standards of efficacy, 
safety and cost-effectiveness. 
FUTURE PERSPECTIVES 
The complexity of the interaction of nutrition and gastrointestinal function, and 
the potential of nutritional support to improve the outcome of critical illness, jus-
tify the allocation of resources to further knowledge in this field. Fundamental re-
search will have to clarify the significance of poor gastrointestinal function in criti-
cal illness and its relation with ‘gut-derived’ sepsis and multiple organ failure, to 
identify immunonutritive effects of individual nutrients, including trophic effects 
on the gastrointestinal tract, and to clarify the mechanisms of the interaction of 
sepsis, sex and cholestasis. Of particular importance to the setting of pediatric 
critical illness and pediatric surgery, however, is the initiation of clinical research 
that seeks to translate fundamental insights into clinically applicable strategies for 
nutrition support. The research on the nonnutritive effects of glutamine may 
serve to illustrate this point. An abundance of animal experiments and several 
prospective randomised trials in critically ill adult patients suggest that glutamine 
may exert beneficial effects in selected patients, but the evidence is judged insuf-
ficient to include glutamine supplementation in adult guidelines for nutritional 
support.29 Promising results of enteral glutamine supplementation in prospective, 
but small, and not very well controlled, trials in low birthweight infants have sub-
sequently been refuted by one large, well controlled multi-center trial.56 The 
studies on intestinal permeability that we presented in this thesis illustrate the 
drawbacks of using surrogate endpoints instead of hard endpoints, like mortality, 
sepsis incidence, resource usage and length of ICU and hospital stay. In view of 
the necessary homogeneity of the study population, the limited numbers of pa-
tients with a specific disease, the variability of the natural course of the diseases 
of interest, and the relatively low incidence of relevant hard endpoints in the pe-
diatric population, designing and executing the multi-center prospective trials 
needed to test the notions discussed earlier and to improve nutritional support 
will truly be a challenge. 
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In de context van ernstige ziekte, grote chirurgische ingrepen en een slechte 
functie van het maagdarmkanaal is het kiezen van een voedingswijze een delicate 
aangelegenheid. Dit proefschrift bevat studies naar de voedingswijze van pas-
geborenen en zuigelingen die een chirurgische behandeling ondergingen van aan-
doeningen die gepaard gingen met een slechte functie van het maagdarmkanaal. 
In Hoofdstuk 2 wordt de verhouding van de urine-uitscheidingen van enteraal 
toegediend lactulose en rhamnose –een maat voor darmpermeabiliteit– van der-
tien premature pasgeborenen die chirurgisch behandeld werden vanwege een ne-
crotiserende enterocolitis, vergeleken met die van tien pasgeborenen die om an-
dere redenen chirurgische behandeling ondergingen. Meestal bleef bij patiënten 
met necrotiserende enterocolitis gedurende de eerste week na operatieve behan-
deling de darmpermeabiliteit verhoogd. In sommige patiënten normaliseerde de 
darmpermeabiliteit in de tweede of derde week, terwijl de darmpermeabiliteit bij 
anderen ook gedurende de derde week na chirurgie verhoogd bleef. Een verho-
ging van de darmpermeabiliteit die optrad in de tweede of derde week na chirur-
gie viel steeds samen met een episode van sepsis of darmobstructie. De darmper-
meabiliteit van controle-patiënten normaliseerde in de eerste week na de opera-
tieve ingreep. Wij maakten hieruit op dat het voortduren van verhoogde darmper-
meabiliteit na de eerste postoperatieve week moet worden toegeschreven aan de 
onderliggende ziekte, in casu necrotiserende enterocolitis. Voorts lijkt maatwerk 
bij de herintroductie van enterale voeding aangewezen, maar zou men zich hierbij 
niet alleen moeten laten leiden door lactose-rhamnoseratio’s. 
In Hoofdstuk 3 gebruikten we dezelfde test voor darmpermeabiliteit, in combi-
natie met tests voor “carrier-mediated” transport, bij pasgeborenen die behan-
deld werden met extracorporele membraanoxygenatie. We vergeleken zeven pati-
enten die enteraal gevoed werden met negen patiënten die volledig parenteraal 
gevoed werden. In dertien van deze zestien patiënten was de permeabiliteit van 
de darm toegenomen. De urine-uitscheiding van D-xylose, een maat voor passief 
“carrier-mediated” transport, was in beide groepen patiënten normaal. De urine-
uitscheiding van 3-O-methyl-D-glucose, een maat voor actief “carrrier-mediated” 
transport, was vergelijkbaar laag in beide groepen patiënten. Noch de excretiera-
tio van lactulose-rhamnose, noch enige andere parameter veranderde na intro-
ductie van enterale voeding. Wij maakten hieruit op dat de permeabiliteit van de 
darm en het transport over de darmwand in alle patiënten aangetast waren, on-
geacht de voedingswijze, en dat het starten van enterale voeding niet leidde tot 
een verdere verslechtering. Onze bevindingen bieden geen steun voor het ont-
houden van enterale voeding aan patiënten die met extracorporele membraan-
oxygenatie behandeld worden. 
In de studie beschreven in Hoofdstuk 4 onderzochten we het effect van de voe-
dingswijze op de incidentie van septische complicaties bij pasgeborenen die be-
handeld werden met extracorporele membraanoxygenatie. Hoewel de extracorpo-
rele membraanoxygenatie langer duurde in de groep enteraal gevoede patiënten, 
verschilde de frequentie van septische complicaties in deze zestien patiënten niet 
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van die in de vijfendertig patiënten die alleen parenteraal gevoed werden. Van de 
11 septische complicaties waarvan een microbiële verwekker gevonden werd, 
werden er 8 veroorzaakt door een coagulase-negatieve stafylokok. Deze episodes 
werden dan ook niet toegeschreven aan een verstoring van de darmintegriteit, 
maar aan het gebruik van centraal-veneuze catheters en arteriële en veneuze ca-
nules. Nadelige effecten van enterale voeding werden niet gevonden. Opnieuw 
werden geen argumenten gevonden om enterale voeding te onthouden aan pas-
geborenen die behandeld worden met extracorporele membraanoxygenatie. 
In Hoofdstuk 5 wordt een cohort pasgeborenen met een intrinsieke anomalie 
van het maagdarmkanaal beschreven die gedurende minimaal zeven dagen na 
een operatieve behandeling parenteraal gevoed werden. We vergeleken de inci-
dentie van sepsis in zesentwintig patiënten die parenterale voeding-geassocieerde 
cholestase ontwikkelden met de sepsis-incidentie in tweeënzeventig patiënten die 
geen cholestase ontwikkelden. De incidentie van sepsis was weliswaar iets hoger 
in de patiënten die cholestase ontwikkelden, maar gemiddeld over alle patiënten 
was de sepsis-incidentie laag (9 episoden per 1000 ziekenhuisdagen). Zevenen-
dertig van de 56 gekweekte microörganismen waren coagulase-negatieve stafylo-
kokken. Zoals hierboven al werd opgemerkt, worden infecties met dit microörga-
nisme toegeschreven aan het gebruik van toegangstechnieken voor het vaatbed, 
en niet aan darmpathologie. Parenterale voeding-geassocieerde cholestase ont-
stond en ontwikkelde zich zonder enige septische episode in dertien van de zes-
entwintig patiënten. Zowel sepsis als cholestase werden vaker bij mannelijke dan 
bij vrouwelijke pasgeborenen gezien. Wij concludeerden hieruit dat sepsis een 
epifenomeen is van parenterale voeding-geassocieerde cholestase, en geen cau-
sale factor. 
In Hoofdstuk 6 vergeleken wij de stikstofuitscheiding niet-via-urine met de stik-
stofuitscheiding via urine bij achtenzeventig pasgeborenen en zuigelingen die op 
de vierde tot de zesde dag na maag-darmchirurgie totaal parenteraal gevoed 
werden. Zowel de stikstofuitscheiding niet-via-urine als die via urine, én de ver-
houding tussen deze twee, varieerde sterk. Hoewel relatief eenvoudige voorspel-
lende vergelijkingen een redelijke schatting opleverden van het stikstofverlies 
niet-via-urine, bleef in individuele gevallen aanzienlijke imprecisie bestaan. Wij 
trokken de conclusie dat het stikstofverlies niet-via-urine niet veronachtzaamd 
mag worden en dat het meten van het stikstofverlies via álle excreta de enige 
manier is om tot een juiste inschatting van het totale stikstofverlies te komen. 
In Hoofdstuk 7 worden de effecten beschreven van isonitrogene isocalorische 
glutamine-suppletie van parenterale voeding bij pasgeborenen en zuigelingen die 
een grote operatie aan het maagdarmkanaal ondergingen. In een dubbelblinde 
gerandomiseerde gecontroleerde trial vergeleken wij eenenveertig patiënten die 
glutamine-gesuppleerde parenterale voeding kregen met negenendertig patiënten 
die gewone parenterale voeding kregen. In het merendeel van de patiënten was 
de darmpermeabiliteit na de operatieve ingreep verhoogd en bleef deze verhoogd 
gedurende de studieperiode. Glutamine-suppletie had geen meetbaar effect op de 
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darmpermeabiliteit, de stikstofbalans, de incidentie van septische episoden en het 
gebruik van antibiotica of IC-middelen. Evenmin werd een effect gevonden op 
mortaliteit en duur van IC- of ziekenhuisopname. Wij concludeerden dat 
glutaminesuppletie in deze categorie patiënten niet aangewezen is. 
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